,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,36420,936,Drug Gene Interaction database (DGIdb),Niacinamide,,NIACINAMIDE,https://www.dgidb.org/drugs/NIACINAMIDE,,PARP1,https://www.dgidb.org/genes/PARP1,,,142,PARP1,9606,Homo sapiens (human),,,,,,,,
1,57717,936,Drug Gene Interaction database (DGIdb),Niacinamide,,NIACINAMIDE,https://www.dgidb.org/drugs/NIACINAMIDE,,SIRT3,https://www.dgidb.org/genes/SIRT3,,,23410,SIRT3,9606,Homo sapiens (human),,,,PMID:22835719,https://www.ncbi.nlm.nih.gov/pubmed/22835719,22835719,,
2,57718,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,31,ACACA,https://ctdbase.org/detail.go?type=gene&acc=31,,,31,ACACA,9606,Homo sapiens (human),"Niacinamide inhibits the reaction [6,8-diallyl 5,7-dihydroxy 2-(2-allyl 3-hydroxy 4-methoxyphenyl)1-H benzo(b)pyran-4-one results in increased phosphorylation of ACACA protein]",,,PMID:18482975,https://www.ncbi.nlm.nih.gov/pubmed/18482975,18482975,,
3,57719,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,31,ACACA,https://ctdbase.org/detail.go?type=gene&acc=31,,,31,ACACA,9606,Homo sapiens (human),Niacinamide results in decreased phosphorylation of ACACA protein,,,PMID:19071085,https://www.ncbi.nlm.nih.gov/pubmed/19071085,19071085,,
4,57720,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,31,ACACA,https://ctdbase.org/detail.go?type=gene&acc=31,,,31,ACACA,10116,Rattus norvegicus (Norway rat),[niacinamide results in decreased activity of SIRT1 protein] inhibits the reaction [fructose results in increased expression of ACACA mrna],,,PMID:21212096,https://www.ncbi.nlm.nih.gov/pubmed/21212096,21212096,,
5,57721,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1636,ACE,https://ctdbase.org/detail.go?type=gene&acc=1636,,,1636,ACE,10090,Mus musculus (house mouse),"2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of ACE mrna]|metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of ACE mrna]|[streptozocin co-treated with niacinamide] results in increased expression of ACE mRNA",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
6,57722,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,59272,ACE2,https://ctdbase.org/detail.go?type=gene&acc=59272,,,59272,ACE2,10090,Mus musculus (house mouse),"[streptozocin co-treated with niacinamide] results in decreased expression of ACE2 mrna|metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of ACE2 mrna]|2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of ACE2 mrna]",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
7,57723,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370,ADIPOQ,10090,Mus musculus (house mouse),Niacinamide results in increased secretion of ADIPOQ protein,,,PMID:17452443,https://www.ncbi.nlm.nih.gov/pubmed/17452443,17452443,,
8,57870,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370,ADIPOQ,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in decreased expression of ADIPOQ protein|resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of ADIPOQ protein],,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
9,57871,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,27161,AGO2,https://ctdbase.org/detail.go?type=gene&acc=27161,,,27161,AGO2,10090,Mus musculus (house mouse),"Niacinamide affects the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of AGO2 mrna]|niacinamide affects the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of AGO2 protein]",,,PMID:24792773,https://www.ncbi.nlm.nih.gov/pubmed/24792773,24792773,,
10,57872,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,185,AGTR1,https://ctdbase.org/detail.go?type=gene&acc=185,,,185,AGTR1,10116,Rattus norvegicus (Norway rat),[niacinamide results in decreased activity of SIRT1 protein] inhibits the reaction [resveratrol results in decreased expression of AGTR1 mrna]|[niacinamide results in decreased activity of SIRT1 protein] which results in increased expression of AGTR1 mRNA,,,PMID:18420994,https://www.ncbi.nlm.nih.gov/pubmed/18420994,18420994,,
11,57873,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,11607,AGTR1A,https://ctdbase.org/detail.go?type=gene&acc=11607,,,11607,Agtr1a,10090,Mus musculus (house mouse),"Metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of AGTR1A mrna]|[streptozocin co-treated with niacinamide] results in increased expression of AGTR1A mrna|2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of AGTR1A mrna]",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
12,57874,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,317,APAF1,https://ctdbase.org/detail.go?type=gene&acc=317,,,317,APAF1,10090,Mus musculus (house mouse),"[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of APAF1 mrna]|[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of APAF1 protein]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of APAF1 mrna]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of APAF1 protein]",,,PMID:25478867,https://www.ncbi.nlm.nih.gov/pubmed/25478867,25478867,,
13,57875,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581,BAX,9606,Homo sapiens (human),[berberine co-treated with niacinamide] results in increased expression of BAX protein|niacinamide results in increased expression of BAX protein,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
14,57876,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581,BAX,9606,Homo sapiens (human),Niacinamide results in increased expression of BAX mRNA,,,PMID:16998810,https://www.ncbi.nlm.nih.gov/pubmed/16998810,16998810,,
15,57877,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581,BAX,10090,Mus musculus (house mouse),"[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of BAX protein]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of BAX mrna]|[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of BAX mrna]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of BAX protein]",,,PMID:25478867,https://www.ncbi.nlm.nih.gov/pubmed/25478867,25478867,,
16,58022,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581,BAX,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [methylnitrosourea results in increased expression of BAX protein],,,PMID:16168987,https://www.ncbi.nlm.nih.gov/pubmed/16168987,16168987,,
17,58023,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581,BAX,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [thiotepa results in increased expression of BAX protein]|niacinamide inhibits the reaction [thiotepa results in increased expression of BAX mrna],,,PMID:22164206,https://www.ncbi.nlm.nih.gov/pubmed/22164206,22164206,,
18,58024,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,27113,BBC3,https://ctdbase.org/detail.go?type=gene&acc=27113,,,27113,BBC3,9606,Homo sapiens (human),[berberine co-treated with niacinamide] results in increased expression of BBC3 mrna|niacinamide results in increased expression of BBC3 mRNA,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
19,58025,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596,BCL2,9606,Homo sapiens (human),[berberine co-treated with niacinamide] results in decreased expression of BCL2 protein,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
20,58026,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596,BCL2,9606,Homo sapiens (human),Niacinamide promotes the reaction [[oxygen co-treated with oxygen deficiency] results in decreased expression of BCL2 protein],,,PMID:25472572,https://www.ncbi.nlm.nih.gov/pubmed/25472572,25472572,,
21,58027,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596,BCL2,10090,Mus musculus (house mouse),"[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of BCL2 mrna]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]|[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of BCL2 mrna]",,,PMID:25478867,https://www.ncbi.nlm.nih.gov/pubmed/25478867,25478867,,
22,58028,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,10018,BCL2L11,https://ctdbase.org/detail.go?type=gene&acc=10018,,,10018,BCL2L11,9606,Homo sapiens (human),[berberine co-treated with niacinamide] results in increased expression of BCL2L11 mrna|niacinamide results in increased expression of BCL2L11 mRNA,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
23,58029,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,10018,BCL2L11,https://ctdbase.org/detail.go?type=gene&acc=10018,,,10018,BCL2L11,9606,Homo sapiens (human),Niacinamide promotes the reaction [[oxygen co-treated with oxygen deficiency] results in increased expression of BCL2L11 protein],,,PMID:25472572,https://www.ncbi.nlm.nih.gov/pubmed/25472572,25472572,,
24,58030,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,648,BMI1,https://ctdbase.org/detail.go?type=gene&acc=648,,,648,BMI1,10090,Mus musculus (house mouse),"Niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of BMI1 mrna]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of BMI1 protein]",,,PMID:24792773,https://www.ncbi.nlm.nih.gov/pubmed/24792773,24792773,,
25,58164,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),[berberine co-treated with niacinamide] results in increased cleavage of CASP3 protein,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
26,58165,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),Niacinamide results in increased cleavage of CASP3 protein,,,PMID:24962570|PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/24962570|https://www.ncbi.nlm.nih.gov/pubmed/26712469,24962570|26712469,,
27,58166,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),Resveratrol inhibits the reaction [niacinamide results in increased cleavage of CASP3 protein],,,PMID:24962570,https://www.ncbi.nlm.nih.gov/pubmed/24962570,24962570,,
28,58167,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,10090,Mus musculus (house mouse),"Niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mrna]|[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mrna]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased activity of CASP3 protein]|[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased activity of CASP3 protein]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein]|[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein]",,,PMID:25478867,https://www.ncbi.nlm.nih.gov/pubmed/25478867,25478867,,
29,58168,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,10090,Mus musculus (house mouse),Niacinamide promotes the reaction [antimycin A results in increased cleavage of CASP3 protein]|niacinamide promotes the reaction [hydrogen peroxide results in increased cleavage of CASP3 protein],,,PMID:24040102,https://www.ncbi.nlm.nih.gov/pubmed/24040102,24040102,,
30,58169,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [hydrogen peroxide results in increased cleavage of CASP3 protein],,,PMID:16505238,https://www.ncbi.nlm.nih.gov/pubmed/16505238,16505238,,
31,58170,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [thiotepa results in increased activity of CASP3 protein],,,PMID:22164206,https://www.ncbi.nlm.nih.gov/pubmed/22164206,22164206,,
32,58171,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842,CASP9,9606,Homo sapiens (human),[berberine co-treated with niacinamide] results in increased cleavage of CASP9 protein,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
33,58172,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277,COL1A1,10090,Mus musculus (house mouse),Niacinamide results in decreased expression of COL1A1 mRNA,,,PMID:16813520,https://www.ncbi.nlm.nih.gov/pubmed/16813520,16813520,,
34,58325,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1278,COL1A2,https://ctdbase.org/detail.go?type=gene&acc=1278,,,1278,COL1A2,9606,Homo sapiens (human),Niacinamide inhibits the reaction [resveratrol inhibits the reaction [TGFB2 protein results in increased expression of COL1A2 mrna]],,,PMID:25707573,https://www.ncbi.nlm.nih.gov/pubmed/25707573,25707573,,
35,58326,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842,CASP9,10090,Mus musculus (house mouse),"[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mrna]|[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]|[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mrna]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]",,,PMID:25478867,https://www.ncbi.nlm.nih.gov/pubmed/25478867,25478867,,
36,58327,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842,CASP9,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [hydrogen peroxide results in increased cleavage of CASP9 protein],,,PMID:16505238,https://www.ncbi.nlm.nih.gov/pubmed/16505238,16505238,,
37,58328,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10090,Mus musculus (house mouse),"[streptozocin co-treated with niacinamide] results in decreased activity of CAT protein|2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of CAT protein]|metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of CAT protein]",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
38,58329,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10116,Rattus norvegicus (Norway rat),Coumarin inhibits the reaction [[niacinamide co-treated with streptozocin] results in decreased activity of CAT protein],,,PMID:21630391,https://www.ncbi.nlm.nih.gov/pubmed/21630391,21630391,,
39,58330,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10116,Rattus norvegicus (Norway rat),Diosmin inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of CAT protein],,,PMID:22056647,https://www.ncbi.nlm.nih.gov/pubmed/22056647,22056647,,
40,58331,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[niacinamide co-treated with streptozocin] results in decreased activity of CAT protein]|gliclazide inhibits the reaction [[niacinamide co-treated with streptozocin] results in decreased activity of CAT protein],,,PMID:20307516,https://www.ncbi.nlm.nih.gov/pubmed/20307516,20307516,,
41,58332,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10116,Rattus norvegicus (Norway rat),Gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of CAT protein],,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
42,58333,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10116,Rattus norvegicus (Norway rat),[niacinamide co-treated with streptozocin] results in decreased activity of CAT protein,,,PMID:20307516|PMID:21630391,https://www.ncbi.nlm.nih.gov/pubmed/20307516|https://www.ncbi.nlm.nih.gov/pubmed/21630391,20307516|21630391,,
43,58495,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10116,Rattus norvegicus (Norway rat),Pioglitazone inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of CAT protein]|saponins inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of CAT protein],,,PMID:29247773,https://www.ncbi.nlm.nih.gov/pubmed/29247773,29247773,,
44,58496,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of CAT protein],,,PMID:21439372|PMID:23677724,https://www.ncbi.nlm.nih.gov/pubmed/21439372|https://www.ncbi.nlm.nih.gov/pubmed/23677724,21439372|23677724,,
45,58497,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in decreased activity of CAT protein,,,PMID:21382363|PMID:21439372|PMID:22056647|PMID:23677724|PMID:29247773,https://www.ncbi.nlm.nih.gov/pubmed/21382363|https://www.ncbi.nlm.nih.gov/pubmed/21439372|https://www.ncbi.nlm.nih.gov/pubmed/22056647|https://www.ncbi.nlm.nih.gov/pubmed/23677724|https://www.ncbi.nlm.nih.gov/pubmed/29247773,21382363|21439372|22056647|23677724|29247773,,
46,58498,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10116,Rattus norvegicus (Norway rat),Thymoquinone inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of CAT protein],,,PMID:21382363,https://www.ncbi.nlm.nih.gov/pubmed/21382363,21382363,,
47,58499,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347,CCL2,9606,Homo sapiens (human),Niacinamide results in decreased expression of CCL2 protein,,,PMID:14627904,https://www.ncbi.nlm.nih.gov/pubmed/14627904,14627904,,
48,58500,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6364,CCL20,https://ctdbase.org/detail.go?type=gene&acc=6364,,,6364,CCL20,9606,Homo sapiens (human),Niacinamide results in increased expression of CCL20 mRNA,,,PMID:22385246,https://www.ncbi.nlm.nih.gov/pubmed/22385246,22385246,,
49,58501,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,952,CD38,https://ctdbase.org/detail.go?type=gene&acc=952,,,952,CD38,10090,Mus musculus (house mouse),CD38 gene mutant form promotes the reaction [niacinamide inhibits the reaction [NADP promotes the reaction [FASL protein results in increased abundance of NAADP]]],,,PMID:20200208,https://www.ncbi.nlm.nih.gov/pubmed/20200208,20200208,,
50,58502,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,958,CD40,https://ctdbase.org/detail.go?type=gene&acc=958,,,958,CD40,10090,Mus musculus (house mouse),Niacinamide promotes the reaction [TNF protein results in increased expression of CD40 mrna],,,PMID:22717288,https://www.ncbi.nlm.nih.gov/pubmed/22717288,22717288,,
51,58503,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026,CDKN1A,9606,Homo sapiens (human),Niacinamide results in decreased expression of CDKN1A protein|niacinamide inhibits the reaction [tert-butylhydroperoxide results in increased expression of CDKN1A protein],,,PMID:12782109,https://www.ncbi.nlm.nih.gov/pubmed/12782109,12782109,,
52,58504,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026,CDKN1A,10090,Mus musculus (house mouse),"Niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A protein]|[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A mrna]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A mrna]|[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A protein]",,,PMID:25478867,https://www.ncbi.nlm.nih.gov/pubmed/25478867,25478867,,
53,58670,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026,CDKN1A,10116,Rattus norvegicus (Norway rat),Niacinamide results in increased expression of CDKN1A protein|niacinamide inhibits the reaction [sirolimus inhibits the reaction [glucose results in increased expression of CDKN1A protein]],,,PMID:22561310,https://www.ncbi.nlm.nih.gov/pubmed/22561310,22561310,,
54,58671,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1027,CDKN1B,https://ctdbase.org/detail.go?type=gene&acc=1027,,,1027,CDKN1B,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [sirolimus inhibits the reaction [glucose results in increased expression of CDKN1B protein]]|niacinamide results in increased expression of CDKN1B protein,,,PMID:22561310,https://www.ncbi.nlm.nih.gov/pubmed/22561310,22561310,,
55,58672,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1029,CDKN2A,https://ctdbase.org/detail.go?type=gene&acc=1029,,,1029,CDKN2A,10090,Mus musculus (house mouse),"Niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A mrna]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased methylation of CDKN2A promoter]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A protein]",,,PMID:24792773,https://www.ncbi.nlm.nih.gov/pubmed/24792773,24792773,,
56,58673,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1147,CHUK,https://ctdbase.org/detail.go?type=gene&acc=1147,,,1147,CHUK,9606,Homo sapiens (human),Niacinamide results in increased activity of CHUK protein|resveratrol inhibits the reaction [niacinamide results in increased activity of CHUK protein],,,PMID:24962570,https://www.ncbi.nlm.nih.gov/pubmed/24962570,24962570,,
57,58674,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277,COL1A1,9606,Homo sapiens (human),Niacinamide inhibits the reaction [resveratrol inhibits the reaction [TGFB2 protein results in increased expression of COL1A1 mrna]],,,PMID:25707573,https://www.ncbi.nlm.nih.gov/pubmed/25707573,25707573,,
58,58675,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4512,COX1,https://ctdbase.org/detail.go?type=gene&acc=4512,,,4512,COX1,9606,Homo sapiens (human),Niacinamide results in increased expression of COX1 mrna|niacinamide results in increased expression of COX1 protein,,,PMID:23738040,https://www.ncbi.nlm.nih.gov/pubmed/23738040,23738040,,
59,58676,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576,CXCL8,9606,Homo sapiens (human),"[niacinamide co-treated with lipopolysaccharide, E. coli O26-B6] results in decreased expression of CXCL8 mRNA",,,PMID:29594315,https://www.ncbi.nlm.nih.gov/pubmed/29594315,29594315,,
60,58677,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576,CXCL8,9606,Homo sapiens (human),[niacinamide results in decreased activity of SIRT1 protein] which results in increased expression of CXCL8 mRNA,,,PMID:24894820,https://www.ncbi.nlm.nih.gov/pubmed/24894820,24894820,,
61,58678,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576,CXCL8,9606,Homo sapiens (human),Niacinamide results in increased expression of CXCL8 mRNA,,,PMID:22385246,https://www.ncbi.nlm.nih.gov/pubmed/22385246,22385246,,
62,58679,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576,CXCL8,9606,Homo sapiens (human),"Niacinamide inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of CXCL8 mrna]",,,PMID:24603311,https://www.ncbi.nlm.nih.gov/pubmed/24603311,24603311,,
63,58853,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1535,CYBA,https://ctdbase.org/detail.go?type=gene&acc=1535,,,1535,CYBA,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [niacinamide results in increased expression of CYBA mrna]|gw 6471 inhibits the reaction [resveratrol inhibits the reaction [niacinamide results in increased expression of CYBA mrna]]|niacinamide results in increased expression of CYBA mrna|clofibrate inhibits the reaction [niacinamide results in increased expression of CYBA mrna],,,PMID:23422569,https://www.ncbi.nlm.nih.gov/pubmed/23422569,23422569,,
64,58854,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1586,CYP17A1,https://ctdbase.org/detail.go?type=gene&acc=1586,,,1586,CYP17A1,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [letrozole results in increased expression of CYP17A1 mrna],,,PMID:32298659,https://www.ncbi.nlm.nih.gov/pubmed/32298659,32298659,,
65,58855,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543,CYP1A1,9031,Gallus gallus (chicken),Niacinamide inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of CYP1A1 mrna]|niacinamide inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein],,,PMID:20876576,https://www.ncbi.nlm.nih.gov/pubmed/20876576,20876576,,
66,58856,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,664714,CYP1A5,https://ctdbase.org/detail.go?type=gene&acc=664714,,,664714,,9031,Gallus gallus (chicken),Niacinamide inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of CYP1A5 mrna]|niacinamide inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of CYP1A5 protein],,,PMID:20876576,https://www.ncbi.nlm.nih.gov/pubmed/20876576,20876576,,
67,58857,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,226143,CYP2C23,https://ctdbase.org/detail.go?type=gene&acc=226143,,,226143,Cyp2c23,10116,Rattus norvegicus (Norway rat),[methionine co-treated with thiamine co-treated with niacinamide co-treated with alpha-tocopherol co-treated with zinc] inhibits the reaction [[isoniazid co-treated with rifampin co-treated with ethambutol co-treated with pyrazinamide] results in increased expression of CYP2C23 mrna],,,PMID:27919644,https://www.ncbi.nlm.nih.gov/pubmed/27919644,27919644,,
68,58858,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571,CYP2E1,10116,Rattus norvegicus (Norway rat),[methionine co-treated with thiamine co-treated with niacinamide co-treated with alpha-tocopherol co-treated with zinc] inhibits the reaction [[isoniazid co-treated with rifampin co-treated with ethambutol co-treated with pyrazinamide] results in increased activity of CYP2E1 protein]|[methionine co-treated with thiamine co-treated with niacinamide co-treated with alpha-tocopherol co-treated with zinc] inhibits the reaction [[isoniazid co-treated with rifampin co-treated with ethambutol co-treated with pyrazinamide] results in increased expression of CYP2E1 mrna],,,PMID:27919644,https://www.ncbi.nlm.nih.gov/pubmed/27919644,27919644,,
69,58859,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4694,NDUFA1,https://ctdbase.org/detail.go?type=gene&acc=4694,,,4694,NDUFA1,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [resveratrol results in increased expression of NDUFA1 mrna],,,PMID:23891692,https://www.ncbi.nlm.nih.gov/pubmed/23891692,23891692,,
70,58860,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,266682,CYP3A2,https://ctdbase.org/detail.go?type=gene&acc=266682,,,266682,Cyp3a2,10116,Rattus norvegicus (Norway rat),[methionine co-treated with thiamine co-treated with niacinamide co-treated with alpha-tocopherol co-treated with zinc] inhibits the reaction [[isoniazid co-treated with rifampin co-treated with ethambutol co-treated with pyrazinamide] results in increased expression of CYP3A2 mrna],,,PMID:27919644,https://www.ncbi.nlm.nih.gov/pubmed/27919644,27919644,,
71,59043,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1673,DEFB4A,https://ctdbase.org/detail.go?type=gene&acc=1673,,,1673,DEFB4A,9606,Homo sapiens (human),[niacinamide results in decreased activity of SIRT1 protein] which results in decreased expression of DEFB4A mRNA,,,PMID:24894820,https://www.ncbi.nlm.nih.gov/pubmed/24894820,24894820,,
72,59044,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23405,DICER1,https://ctdbase.org/detail.go?type=gene&acc=23405,,,23405,DICER1,10090,Mus musculus (house mouse),"Niacinamide affects the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of DICER1 mrna]|niacinamide affects the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of DICER1 protein]",,,PMID:24792773,https://www.ncbi.nlm.nih.gov/pubmed/24792773,24792773,,
73,59045,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1739,DLG1,https://ctdbase.org/detail.go?type=gene&acc=1739,,,1739,DLG1,10090,Mus musculus (house mouse),[niacinamide results in decreased activity of SIRT1 protein] which results in decreased expression of DLG1 mrna|niacinamide inhibits the reaction [geranylgeranylacetone results in increased expression of DLG1 mrna],,,PMID:21232033,https://www.ncbi.nlm.nih.gov/pubmed/21232033,21232033,,
74,59046,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1786,DNMT1,https://ctdbase.org/detail.go?type=gene&acc=1786,,,1786,DNMT1,10090,Mus musculus (house mouse),"Niacinamide affects the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of DNMT1 protein]|niacinamide affects the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of DNMT1 mrna]",,,PMID:24792773,https://www.ncbi.nlm.nih.gov/pubmed/24792773,24792773,,
75,59047,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1978,EIF4EBP1,https://ctdbase.org/detail.go?type=gene&acc=1978,,,1978,EIF4EBP1,9606,Homo sapiens (human),Niacinamide results in increased phosphorylation of EIF4EBP1 protein|niacinamide inhibits the reaction [resveratrol results in decreased phosphorylation of EIF4EBP1 protein],,,PMID:19928762,https://www.ncbi.nlm.nih.gov/pubmed/19928762,19928762,,
76,59048,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1978,EIF4EBP1,https://ctdbase.org/detail.go?type=gene&acc=1978,,,1978,EIF4EBP1,9606,Homo sapiens (human),[niacinamide results in decreased activity of SIRT1 protein] which results in increased phosphorylation of EIF4EBP1 protein,,,PMID:20169165,https://www.ncbi.nlm.nih.gov/pubmed/20169165,20169165,,
77,59049,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2033,EP300,https://ctdbase.org/detail.go?type=gene&acc=2033,,,2033,EP300,9606,Homo sapiens (human),Niacinamide results in increased expression of and results in increased acetylation of EP300 protein,,,PMID:23297412,https://www.ncbi.nlm.nih.gov/pubmed/23297412,23297412,,
78,59050,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2074,ERCC6,https://ctdbase.org/detail.go?type=gene&acc=2074,,,2074,ERCC6,9606,Homo sapiens (human),"ERCC6 gene mutant form promotes the reaction [N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride results in decreased abundance of niacinamide]|ercc6 gene mutant form results in increased abundance of niacinamide",,,PMID:25440059,https://www.ncbi.nlm.nih.gov/pubmed/25440059,25440059,,
79,59051,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2152,F3,https://ctdbase.org/detail.go?type=gene&acc=2152,,,2152,F3,9606,Homo sapiens (human),Niacinamide results in decreased expression of F3 protein,,,PMID:14627904,https://www.ncbi.nlm.nih.gov/pubmed/14627904,14627904,,
80,59052,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,14103,FASL,https://ctdbase.org/detail.go?type=gene&acc=14103,,,14103,Fasl,10090,Mus musculus (house mouse),CD38 gene mutant form promotes the reaction [niacinamide inhibits the reaction [NADP promotes the reaction [FASL protein results in increased abundance of naadp]]]|niacinamide inhibits the reaction [NADP promotes the reaction [FASL protein results in increased abundance of NAADP]],,,PMID:20200208,https://www.ncbi.nlm.nih.gov/pubmed/20200208,20200208,,
81,59194,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353,FOS,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [methylnitrosourea results in increased expression of FOS protein],,,PMID:16168987,https://www.ncbi.nlm.nih.gov/pubmed/16168987,16168987,,
82,59195,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2308,FOXO1,https://ctdbase.org/detail.go?type=gene&acc=2308,,,2308,FOXO1,9606,Homo sapiens (human),Niacinamide results in increased expression of and results in increased acetylation of FOXO1 protein|[berberine co-treated with niacinamide] results in increased expression of and results in increased acetylation of FOXO1 protein,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
83,59196,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2308,FOXO1,https://ctdbase.org/detail.go?type=gene&acc=2308,,,2308,FOXO1,10090,Mus musculus (house mouse),Niacinamide inhibits the reaction [FOXO1 protein results in increased expression of G6PC1 mrna]|niacinamide inhibits the reaction [FOXO1 protein results in increased expression of IGFBP1 mrna],,,PMID:16917544,https://www.ncbi.nlm.nih.gov/pubmed/16917544,16917544,,
84,59197,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2308,FOXO1,https://ctdbase.org/detail.go?type=gene&acc=2308,,,2308,FOXO1,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [dexamethasone results in decreased acetylation of FOXO1 protein]|niacinamide inhibits the reaction [FOXO1 protein binds to SIRT1 protein],,,PMID:20181797,https://www.ncbi.nlm.nih.gov/pubmed/20181797,20181797,,
85,59198,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2308,FOXO1,https://ctdbase.org/detail.go?type=gene&acc=2308,,,2308,FOXO1,9823,Sus scrofa (pig),Niacinamide results in increased expression of FOXO1 mRNA,,,PMID:17851734,https://www.ncbi.nlm.nih.gov/pubmed/17851734,17851734,,
86,59199,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [methylnitrosourea results in increased activity of PARP1 protein],,,PMID:16168987,https://www.ncbi.nlm.nih.gov/pubmed/16168987,16168987,,
87,59200,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2308,FOXO1,https://ctdbase.org/detail.go?type=gene&acc=2308,,,2308,FOXO1,9606,Homo sapiens (human),Niacinamide inhibits the reaction [resveratrol results in increased localization of FOXO1 protein]|niacinamide results in increased acetylation of FOXO1 protein|niacinamide inhibits the reaction [hydrogen peroxide results in increased localization of FOXO1 protein]|niacinamide affects the localization of FOXO1 protein|[niacinamide co-treated with trichostatin A] inhibits the reaction [FOXO1 protein binds to SIRT1 protein],,,PMID:15788402,https://www.ncbi.nlm.nih.gov/pubmed/15788402,15788402,,
88,59201,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2309,FOXO3,https://ctdbase.org/detail.go?type=gene&acc=2309,,,2309,FOXO3,9606,Homo sapiens (human),Niacinamide results in increased expression of and results in increased acetylation of FOXO3 protein|[berberine co-treated with niacinamide] results in increased expression of and results in increased acetylation of FOXO3 protein,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
89,59202,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2309,FOXO3,https://ctdbase.org/detail.go?type=gene&acc=2309,,,2309,FOXO3,9606,Homo sapiens (human),Niacinamide inhibits the reaction [icariin inhibits the reaction [[oxygen co-treated with oxygen deficiency] results in increased acetylation of and results in increased expression of FOXO3 protein]]|niacinamide promotes the reaction [[oxygen co-treated with oxygen deficiency] results in increased acetylation of FOXO3 protein],,,PMID:25472572,https://www.ncbi.nlm.nih.gov/pubmed/25472572,25472572,,
90,59324,936,Toxin and Toxin Target Database (T3DB),Niacinamide,T3D4168,Niacinamide,http://www.t3db.ca/toxins/T3D4168,BE0002461,NAD-dependent protein deacetylase sirtuin-1,http://www.t3db.ca/biodb/bio_entities/BE0002461,Q96EB6,NAD-dependent protein deacetylase sirtuin-1,23411,SIRT1,9606,Homo sapiens (human),,,,PMID:25041433|PMID:22419041|PMID:17145705|PMID:19700324|PMID:23318905|PMID:19734050|PMID:16697640,https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041|https://www.ncbi.nlm.nih.gov/pubmed/17145705|https://www.ncbi.nlm.nih.gov/pubmed/19700324|https://www.ncbi.nlm.nih.gov/pubmed/23318905|https://www.ncbi.nlm.nih.gov/pubmed/19734050|https://www.ncbi.nlm.nih.gov/pubmed/16697640,25041433|22419041|17145705|19700324|23318905|19734050|16697640,,
91,59325,936,Toxin and Toxin Target Database (T3DB),Niacinamide,T3D4168,Niacinamide,http://www.t3db.ca/toxins/T3D4168,BE0005534,NAD-dependent protein deacetylase sirtuin-2,http://www.t3db.ca/biodb/bio_entities/BE0005534,Q8IXJ6,NAD-dependent protein deacetylase sirtuin-2,22933,SIRT2,9606,Homo sapiens (human),,,,PMID:25041433|PMID:22419041|PMID:17145705|PMID:19700324|PMID:17149860|PMID:18269226|PMID:15566299,https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041|https://www.ncbi.nlm.nih.gov/pubmed/17145705|https://www.ncbi.nlm.nih.gov/pubmed/19700324|https://www.ncbi.nlm.nih.gov/pubmed/17149860|https://www.ncbi.nlm.nih.gov/pubmed/18269226|https://www.ncbi.nlm.nih.gov/pubmed/15566299,25041433|22419041|17145705|19700324|17149860|18269226|15566299,,
92,59326,936,Toxin and Toxin Target Database (T3DB),Niacinamide,T3D4168,Niacinamide,http://www.t3db.ca/toxins/T3D4168,BE0001717,Poly [ADP-ribose] polymerase 1,http://www.t3db.ca/biodb/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,,,PMID:11752352|PMID:25041433|PMID:22419041|PMID:18809672|PMID:12825952|PMID:20364863|PMID:23481647,https://www.ncbi.nlm.nih.gov/pubmed/11752352|https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041|https://www.ncbi.nlm.nih.gov/pubmed/18809672|https://www.ncbi.nlm.nih.gov/pubmed/12825952|https://www.ncbi.nlm.nih.gov/pubmed/20364863|https://www.ncbi.nlm.nih.gov/pubmed/23481647,11752352|25041433|22419041|18809672|12825952|20364863|23481647,,
93,59357,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2309,FOXO3,https://ctdbase.org/detail.go?type=gene&acc=2309,,,2309,FOXO3,9606,Homo sapiens (human),Niacinamide inhibits the reaction [resveratrol results in increased expression of FOXO3 protein],,,PMID:23022493,https://www.ncbi.nlm.nih.gov/pubmed/23022493,23022493,,
94,59358,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4303,FOXO4,https://ctdbase.org/detail.go?type=gene&acc=4303,,,4303,FOXO4,40674,Mammalia (mammals),Niacinamide inhibits the reaction [SIRT1 protein results in increased activity of FOXO4 protein]|niacinamide results in decreased activity of FOXO4 protein,,,PMID:16012755,https://www.ncbi.nlm.nih.gov/pubmed/16012755,16012755,,
95,59359,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2495,FTH1,https://ctdbase.org/detail.go?type=gene&acc=2495,,,2495,FTH1,9606,Homo sapiens (human),Niacinamide results in increased expression of FTH1 mrna|niacinamide results in increased expression of FTH1 protein,,,PMID:23738040,https://www.ncbi.nlm.nih.gov/pubmed/23738040,23738040,,
96,59360,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2538,G6PC1,https://ctdbase.org/detail.go?type=gene&acc=2538,,,2538,G6PC1,10090,Mus musculus (house mouse),Niacinamide inhibits the reaction [FOXO1 protein results in increased expression of G6PC1 mrna],,,PMID:16917544,https://www.ncbi.nlm.nih.gov/pubmed/16917544,16917544,,
97,59361,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2539,G6PD,https://ctdbase.org/detail.go?type=gene&acc=2539,,,2539,G6PD,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] affects the activity of G6PD protein|resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] affects the activity of G6PD protein],,,PMID:19059388,https://www.ncbi.nlm.nih.gov/pubmed/19059388,19059388,,
98,59362,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2641,GCG,https://ctdbase.org/detail.go?type=gene&acc=2641,,,2641,GCG,10116,Rattus norvegicus (Norway rat),Sitagliptin phosphate inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of GCG mrna]|[streptozocin co-treated with niacinamide] results in decreased expression of GCG mRNA,,,PMID:23466488,https://www.ncbi.nlm.nih.gov/pubmed/23466488,23466488,,
99,59363,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729,GCLC,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of GCLC mrna]|gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of GCLC protein]|resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of GCLC protein]|[streptozocin co-treated with niacinamide] results in decreased expression of GCLC protein|[streptozocin co-treated with niacinamide] results in decreased expression of GCLC mrna|gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of GCLC mrna],,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
100,59364,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2720,GLB1,https://ctdbase.org/detail.go?type=gene&acc=2720,,,2720,GLB1,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [sirolimus inhibits the reaction [glucose results in increased expression of GLB1 protein]]|niacinamide results in increased expression of GLB1 protein,,,PMID:22561310,https://www.ncbi.nlm.nih.gov/pubmed/22561310,22561310,,
101,59365,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2739,GLO1,https://ctdbase.org/detail.go?type=gene&acc=2739,,,2739,GLO1,10116,Rattus norvegicus (Norway rat),Gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of GLO1 protein]|resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of GLO1 protein]|[streptozocin co-treated with niacinamide] results in decreased activity of GLO1 protein,,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
102,59467,936,Toxin and Toxin Target Database (T3DB),Niacinamide,T3D4168,Niacinamide,http://www.t3db.ca/toxins/T3D4168,BE0003362,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0003362,Q9NXA8,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",23408,SIRT5,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235|PMID:25041433|PMID:22419041|PMID:17145705,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235|https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041|https://www.ncbi.nlm.nih.gov/pubmed/17145705,17139284|17016423|10592235|25041433|22419041|17145705,,
103,59468,936,Toxin and Toxin Target Database (T3DB),Niacinamide,T3D4168,Niacinamide,http://www.t3db.ca/toxins/T3D4168,BE0000425,L-lactate dehydrogenase A chain,http://www.t3db.ca/biodb/bio_entities/BE0000425,P00338,L-lactate dehydrogenase A chain,3939,LDHA,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235|PMID:25041433|PMID:22419041,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235|https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041,17139284|17016423|10592235|25041433|22419041,,
104,59469,936,Toxin and Toxin Target Database (T3DB),Niacinamide,T3D4168,Niacinamide,http://www.t3db.ca/toxins/T3D4168,BE0001241,ADP-ribosyl cyclase 2,http://www.t3db.ca/biodb/bio_entities/BE0001241,Q10588,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,683,BST1,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:25041433|PMID:22419041,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041,17139284|17016423|25041433|22419041,,
105,59470,936,Toxin and Toxin Target Database (T3DB),Niacinamide,T3D4168,Niacinamide,http://www.t3db.ca/toxins/T3D4168,BE0004547,"NAD-dependent protein deacetylase sirtuin-3, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0004547,Q9NTG7,"NAD-dependent protein deacetylase sirtuin-3, mitochondrial",23410,SIRT3,9606,Homo sapiens (human),,,,PMID:25041433|PMID:22419041|PMID:17145705|PMID:19700324,https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041|https://www.ncbi.nlm.nih.gov/pubmed/17145705|https://www.ncbi.nlm.nih.gov/pubmed/19700324,25041433|22419041|17145705|19700324,,
106,59471,936,Toxin and Toxin Target Database (T3DB),Niacinamide,T3D4168,Niacinamide,http://www.t3db.ca/toxins/T3D4168,BE0005578,Klotho,http://www.t3db.ca/biodb/bio_entities/BE0005578,Q9UEF7,Klotho,9365,KL,9606,Homo sapiens (human),,,,PMID:25041433|PMID:22419041,https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041,25041433|22419041,,
107,59472,936,Toxin and Toxin Target Database (T3DB),Niacinamide,T3D4168,Niacinamide,http://www.t3db.ca/toxins/T3D4168,BE0005579,NADPH oxidase 4,http://www.t3db.ca/biodb/bio_entities/BE0005579,Q9NPH5,NADPH oxidase 4,50507,NOX4,9606,Homo sapiens (human),,,,PMID:25041433|PMID:22419041,https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041,25041433|22419041,,
108,59473,936,Toxin and Toxin Target Database (T3DB),Niacinamide,T3D4168,Niacinamide,http://www.t3db.ca/toxins/T3D4168,BE0003645,Solute carrier family 22 member 8,http://www.t3db.ca/biodb/bio_entities/BE0003645,Q8TCC7,Solute carrier family 22 member 8,9376,SLC22A8,9606,Homo sapiens (human),,,,PMID:25041433|PMID:22419041,https://www.ncbi.nlm.nih.gov/pubmed/25041433|https://www.ncbi.nlm.nih.gov/pubmed/22419041,25041433|22419041,,
109,59507,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875,GPT,10116,Rattus norvegicus (Norway rat),[resveratrol co-treated with niacinamide] inhibits the reaction [[aflatoxin B1 co-treated with ethanol] results in increased expression of GPT protein],,,PMID:32894639,https://www.ncbi.nlm.nih.gov/pubmed/32894639,32894639,,
110,59508,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936,GSR,10116,Rattus norvegicus (Norway rat),Gliclazide inhibits the reaction [[niacinamide co-treated with streptozocin] results in decreased activity of GSR protein]|resveratrol inhibits the reaction [[niacinamide co-treated with streptozocin] results in decreased activity of GSR protein]|[niacinamide co-treated with streptozocin] results in decreased activity of GSR protein,,,PMID:20307516,https://www.ncbi.nlm.nih.gov/pubmed/20307516,20307516,,
111,59509,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936,GSR,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in decreased activity of GSR protein|gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of GSR protein]|resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of GSR protein],,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
112,59510,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936,GSR,10116,Rattus norvegicus (Norway rat),[niacinamide co-treated with resveratrol] inhibits the reaction [[ethanol co-treated with aflatoxin B1] results in decreased expression of GSR protein],,,PMID:32894639,https://www.ncbi.nlm.nih.gov/pubmed/32894639,32894639,,
113,59511,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2947,GSTM3,https://ctdbase.org/detail.go?type=gene&acc=2947,,,2947,GSTM3,10116,Rattus norvegicus (Norway rat),Gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of GSTM3 mrna]|[streptozocin co-treated with niacinamide] results in decreased expression of GSTM3 mrna|resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of GSTM3 mrna],,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
114,59512,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2950,GSTP1,https://ctdbase.org/detail.go?type=gene&acc=2950,,,2950,GSTP1,10116,Rattus norvegicus (Norway rat),[niacinamide co-treated with resveratrol] inhibits the reaction [[ethanol co-treated with aflatoxin B1] results in increased expression of GSTP1 protein],,,PMID:32894639,https://www.ncbi.nlm.nih.gov/pubmed/32894639,32894639,,
115,59513,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2998,GYS2,https://ctdbase.org/detail.go?type=gene&acc=2998,,,2998,GYS2,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] affects the activity of GYS2 protein|resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] affects the activity of GYS2 protein],,,PMID:19059388,https://www.ncbi.nlm.nih.gov/pubmed/19059388,19059388,,
116,59514,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3039,HBA1,https://ctdbase.org/detail.go?type=gene&acc=3039,,,3039,HBA1,10116,Rattus norvegicus (Norway rat),Coumarin inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased glycosylation of HBA1 protein]|[streptozocin co-treated with niacinamide] results in increased glycosylation of HBA1 protein,,,PMID:19647726,https://www.ncbi.nlm.nih.gov/pubmed/19647726,19647726,,
117,59515,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3065,HDAC1,https://ctdbase.org/detail.go?type=gene&acc=3065,,,3065,HDAC1,10090,Mus musculus (house mouse),"Niacinamide affects the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of HDAC1 mrna]|niacinamide affects the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of HDAC1 protein]",,,PMID:24792773,https://www.ncbi.nlm.nih.gov/pubmed/24792773,24792773,,
118,59668,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156,HMGCR,10116,Rattus norvegicus (Norway rat),Chlorogenic acid results in decreased susceptibility to [[streptozocin co-treated with niacinamide] results in increased activity of HMGCR protein]|[tetrahydrocurcumin co-treated with chlorogenic acid] results in decreased susceptibility to [[streptozocin co-treated with niacinamide] results in increased activity of HMGCR protein]|[streptozocin co-treated with niacinamide] results in increased activity of HMGCR protein|tetrahydrocurcumin results in decreased susceptibility to [[streptozocin co-treated with niacinamide] results in increased activity of HMGCR protein],,,PMID:20696151,https://www.ncbi.nlm.nih.gov/pubmed/20696151,20696151,,
119,59669,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156,HMGCR,10116,Rattus norvegicus (Norway rat),[niacinamide results in decreased activity of SIRT1 protein] inhibits the reaction [fructose results in increased expression of HMGCR mrna],,,PMID:21212096,https://www.ncbi.nlm.nih.gov/pubmed/21212096,21212096,,
120,59670,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162,HMOX1,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of HMOX1 protein]|[streptozocin co-treated with niacinamide] results in decreased expression of HMOX1 protein|gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of HMOX1 protein],,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
121,59671,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383,ICAM1,9606,Homo sapiens (human),Niacinamide inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]],,,PMID:24145604,https://www.ncbi.nlm.nih.gov/pubmed/24145604,24145604,,
122,59672,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458,IFNG,9606,Homo sapiens (human),[niacinamide co-treated with ionomycin co-treated with tetradecanoylphorbol acetate] results in increased expression of IFNG mRNA,,,PMID:29594315,https://www.ncbi.nlm.nih.gov/pubmed/29594315,29594315,,
123,59673,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458,IFNG,9606,Homo sapiens (human),Niacinamide promotes the reaction [tetradecanoylphorbol acetate results in increased expression of IFNG mrna],,,PMID:24603311,https://www.ncbi.nlm.nih.gov/pubmed/24603311,24603311,,
124,59674,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3484,IGFBP1,https://ctdbase.org/detail.go?type=gene&acc=3484,,,3484,IGFBP1,10090,Mus musculus (house mouse),Niacinamide inhibits the reaction [FOXO1 protein results in increased expression of IGFBP1 mrna],,,PMID:16917544,https://www.ncbi.nlm.nih.gov/pubmed/16917544,16917544,,
125,59675,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [thiotepa results in increased cleavage of PARP1 protein],,,PMID:22164206,https://www.ncbi.nlm.nih.gov/pubmed/22164206,22164206,,
126,59676,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586,IL10,10090,Mus musculus (house mouse),"Metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of IL10 mrna]|[streptozocin co-treated with niacinamide] results in decreased expression of IL10 mrna|2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of IL10 protein]|metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of IL10 protein]|[streptozocin co-treated with niacinamide] results in decreased expression of IL10 protein|2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of IL10 mrna]",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
127,59843,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3606,IL18,https://ctdbase.org/detail.go?type=gene&acc=3606,,,3606,IL18,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide co-treated with ENV-2 compound] results in decreased expression of IL18 mRNA,,,PMID:28322830,https://www.ncbi.nlm.nih.gov/pubmed/28322830,28322830,,
128,59844,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553,IL1B,9606,Homo sapiens (human),Niacinamide results in decreased expression of IL1B mRNA,,,PMID:29594315,https://www.ncbi.nlm.nih.gov/pubmed/29594315,29594315,,
129,59845,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553,IL1B,9606,Homo sapiens (human),Niacinamide results in increased expression of IL1B mRNA,,,PMID:22385246,https://www.ncbi.nlm.nih.gov/pubmed/22385246,22385246,,
130,59846,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553,IL1B,10116,Rattus norvegicus (Norway rat),[niacinamide co-treated with streptozocin] results in increased expression of IL1B protein|gliclazide inhibits the reaction [[niacinamide co-treated with streptozocin] results in increased expression of IL1B protein]|resveratrol inhibits the reaction [[niacinamide co-treated with streptozocin] results in increased expression of IL1B protein],,,PMID:20307516,https://www.ncbi.nlm.nih.gov/pubmed/20307516,20307516,,
131,59847,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553,IL1B,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in increased expression of IL1B protein|resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of IL1B protein]|gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of IL1B protein],,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
132,59848,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553,IL1B,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide co-treated with ENV-2 compound] results in decreased expression of IL1B mRNA,,,PMID:28322830,https://www.ncbi.nlm.nih.gov/pubmed/28322830,28322830,,
133,59849,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553,IL1B,9606,Homo sapiens (human),"Niacinamide inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of IL1B mrna]",,,PMID:24603311,https://www.ncbi.nlm.nih.gov/pubmed/24603311,24603311,,
134,59850,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3558,IL2,https://ctdbase.org/detail.go?type=gene&acc=3558,,,3558,IL2,9606,Homo sapiens (human),[niacinamide co-treated with ionomycin co-treated with tetradecanoylphorbol acetate] results in increased expression of IL2 mRNA,,,PMID:29594315,https://www.ncbi.nlm.nih.gov/pubmed/29594315,29594315,,
135,59851,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3558,IL2,https://ctdbase.org/detail.go?type=gene&acc=3558,,,3558,IL2,9606,Homo sapiens (human),Niacinamide promotes the reaction [tetradecanoylphorbol acetate results in increased expression of IL2 mrna],,,PMID:24603311,https://www.ncbi.nlm.nih.gov/pubmed/24603311,24603311,,
136,59852,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,9606,Homo sapiens (human),Niacinamide results in decreased expression of IL6 protein,,,PMID:12727023,https://www.ncbi.nlm.nih.gov/pubmed/12727023,12727023,,
137,59991,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,10116,Rattus norvegicus (Norway rat),Gliclazide inhibits the reaction [[niacinamide co-treated with streptozocin] results in increased expression of IL6 protein]|[niacinamide co-treated with streptozocin] results in increased expression of IL6 protein|resveratrol inhibits the reaction [[niacinamide co-treated with streptozocin] results in increased expression of IL6 protein],,,PMID:20307516,https://www.ncbi.nlm.nih.gov/pubmed/20307516,20307516,,
138,59992,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in increased expression of IL6 protein|resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of IL6 protein]|gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of IL6 protein],,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
139,59993,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630,INS,9606,Homo sapiens (human),Niacinamide inhibits the reaction [glucose inhibits the reaction [MAFA protein binds to INS promoter]]|niacinamide inhibits the reaction [glucose results in increased expression of INS mrna]|niacinamide inhibits the reaction [glucose results in increased expression of INS protein],,,PMID:16505238,https://www.ncbi.nlm.nih.gov/pubmed/16505238,16505238,,
140,59994,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333,Ins1,10116,Rattus norvegicus (Norway rat),[niacinamide co-treated with streptozocin] results in decreased expression of INS1 protein|coumarin inhibits the reaction [[niacinamide co-treated with streptozocin] results in decreased expression of INS1 protein],,,PMID:21630391,https://www.ncbi.nlm.nih.gov/pubmed/21630391,21630391,,
141,59995,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333,Ins1,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in increased expression of INS1 protein|coumarin inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of INS1 protein],,,PMID:19647726,https://www.ncbi.nlm.nih.gov/pubmed/19647726,19647726,,
142,59996,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333,Ins1,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [glucose results in increased expression of INS1 protein],,,PMID:16366736,https://www.ncbi.nlm.nih.gov/pubmed/16366736,16366736,,
143,59997,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333,Ins1,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of INS1 protein],,,PMID:25999625,https://www.ncbi.nlm.nih.gov/pubmed/25999625,25999625,,
144,59998,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333,Ins1,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in decreased expression of INS1 protein,,,PMID:21382363|PMID:25999625,https://www.ncbi.nlm.nih.gov/pubmed/21382363|https://www.ncbi.nlm.nih.gov/pubmed/25999625,21382363|25999625,,
145,59999,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333,Ins1,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in decreased secretion of INS1 protein|thymoquinone inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased secretion of INS1 protein]|thymoquinone inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of INS1 protein],,,PMID:21382363,https://www.ncbi.nlm.nih.gov/pubmed/21382363,21382363,,
146,60156,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725,JUN,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [methylnitrosourea results in increased expression of JUN protein]|niacinamide inhibits the reaction [methylnitrosourea results in increased phosphorylation of JUN protein],,,PMID:16168987,https://www.ncbi.nlm.nih.gov/pubmed/16168987,16168987,,
147,60157,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3741,KCNA5,https://ctdbase.org/detail.go?type=gene&acc=3741,,,3741,KCNA5,9606,Homo sapiens (human),Niacinamide affects the reaction [geranylgeranylacetone results in increased expression of KCNA5 protein],,,PMID:21232033,https://www.ncbi.nlm.nih.gov/pubmed/21232033,21232033,,
148,60158,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,9817,KEAP1,https://ctdbase.org/detail.go?type=gene&acc=9817,,,9817,KEAP1,10090,Mus musculus (house mouse),"[streptozocin co-treated with niacinamide] results in decreased expression of KEAP1 mrna|2,5-dihydroxybenzoic acid promotes the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of KEAP1 mrna]|metformin promotes the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of KEAP1 mrna]",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
149,60159,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,9817,KEAP1,https://ctdbase.org/detail.go?type=gene&acc=9817,,,9817,KEAP1,10116,Rattus norvegicus (Norway rat),Gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of KEAP1 protein]|gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of KEAP1 mrna]|resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of KEAP1 protein]|resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of KEAP1 mrna]|[streptozocin co-treated with niacinamide] results in increased expression of KEAP1 protein|[streptozocin co-treated with niacinamide] results in increased expression of KEAP1 mRNA,,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
150,60160,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,9314,KLF4,https://ctdbase.org/detail.go?type=gene&acc=9314,,,9314,KLF4,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] promotes the reaction [dronabinol results in increased expression of KLF4 mrna],,,PMID:31081965,https://www.ncbi.nlm.nih.gov/pubmed/31081965,31081965,,
151,60161,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3931,LCAT,https://ctdbase.org/detail.go?type=gene&acc=3931,,,3931,LCAT,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in decreased activity of LCAT protein|[tetrahydrocurcumin co-treated with chlorogenic acid] results in decreased susceptibility to [[streptozocin co-treated with niacinamide] results in decreased activity of LCAT protein]|chlorogenic acid results in decreased susceptibility to [[streptozocin co-treated with niacinamide] results in decreased activity of LCAT protein]|tetrahydrocurcumin results in decreased susceptibility to [[streptozocin co-treated with niacinamide] results in decreased activity of LCAT protein],,,PMID:20696151,https://www.ncbi.nlm.nih.gov/pubmed/20696151,20696151,,
152,60162,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3972,LHB,https://ctdbase.org/detail.go?type=gene&acc=3972,,,3972,LHB,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [letrozole results in increased secretion of LHB protein],,,PMID:32298659,https://www.ncbi.nlm.nih.gov/pubmed/32298659,32298659,,
153,60163,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3772547,LNCRNA:HSROMEGA,https://ctdbase.org/detail.go?type=gene&acc=3772547,,,3772547,lncRNA:Hsromega,7227,Drosophila melanogaster (fruit fly),Niacinamide results in increased expression of LNCRNA:HSROMEGA mRNA,,,PMID:9364937,https://www.ncbi.nlm.nih.gov/pubmed/9364937,9364937,,
154,60346,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4023,LPL,https://ctdbase.org/detail.go?type=gene&acc=4023,,,4023,LPL,10116,Rattus norvegicus (Norway rat),[tetrahydrocurcumin co-treated with chlorogenic acid] results in decreased susceptibility to [[streptozocin co-treated with niacinamide] results in decreased activity of LPL protein]|[streptozocin co-treated with niacinamide] results in decreased activity of LPL protein|chlorogenic acid results in decreased susceptibility to [[streptozocin co-treated with niacinamide] results in decreased activity of LPL protein]|tetrahydrocurcumin results in decreased susceptibility to [[streptozocin co-treated with niacinamide] results in decreased activity of LPL protein],,,PMID:20696151,https://www.ncbi.nlm.nih.gov/pubmed/20696151,20696151,,
155,60347,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,81631,MAP1LC3B,https://ctdbase.org/detail.go?type=gene&acc=81631,,,81631,MAP1LC3B,9606,Homo sapiens (human),Niacinamide inhibits the reaction [[TNF protein co-treated with resveratrol] results in increased expression of MAP1LC3B protein alternative form],,,PMID:24145604,https://www.ncbi.nlm.nih.gov/pubmed/24145604,24145604,,
156,60348,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599,MAPK8,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [methylnitrosourea results in increased phosphorylation of MAPK8 protein],,,PMID:16168987,https://www.ncbi.nlm.nih.gov/pubmed/16168987,16168987,,
157,60349,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4193,MDM2,https://ctdbase.org/detail.go?type=gene&acc=4193,,,4193,MDM2,9606,Homo sapiens (human),Niacinamide results in increased expression of MDM2 mRNA,,,PMID:16998810,https://www.ncbi.nlm.nih.gov/pubmed/16998810,16998810,,
158,60350,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,102466056,MIR125B,https://ctdbase.org/detail.go?type=gene&acc=102466056,,,102466056,,10090,Mus musculus (house mouse),"2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of mir125b]|[streptozocin co-treated with niacinamide] results in increased expression of mir125b|metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of MIR125B]",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
159,60351,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,406983,MIR200A,https://ctdbase.org/detail.go?type=gene&acc=406983,,,406983,MIR200A,10090,Mus musculus (house mouse),"Metformin promotes the reaction [[streptozocin co-treated with niacinamide] results in increased expression of mir200a]|[streptozocin co-treated with niacinamide] results in increased expression of MIR200A|2,5-dihydroxybenzoic acid promotes the reaction [[streptozocin co-treated with niacinamide] results in increased expression of MIR200A]",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
160,60352,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,387199,MIR203,https://ctdbase.org/detail.go?type=gene&acc=387199,,,387199,Mir203,10090,Mus musculus (house mouse),"Niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene affects the expression of MIR203 mrna]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased methylation of MIR203 promoter]",,,PMID:24792773,https://www.ncbi.nlm.nih.gov/pubmed/24792773,24792773,,
161,60353,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318,MMP9,9606,Homo sapiens (human),Niacinamide inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]],,,PMID:24145604,https://www.ncbi.nlm.nih.gov/pubmed/24145604,24145604,,
162,60354,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318,MMP9,9606,Homo sapiens (human),Niacinamide results in increased expression of MMP9 protein|resveratrol inhibits the reaction [niacinamide results in increased expression of MMP9 protein],,,PMID:24962570,https://www.ncbi.nlm.nih.gov/pubmed/24962570,24962570,,
163,60482,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4482,MSRA,https://ctdbase.org/detail.go?type=gene&acc=4482,,,4482,MSRA,9606,Homo sapiens (human),Niacinamide inhibits the reaction [resveratrol results in increased expression of MSRA protein],,,PMID:23022493,https://www.ncbi.nlm.nih.gov/pubmed/23022493,23022493,,
164,60483,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,2475,MTOR,https://ctdbase.org/detail.go?type=gene&acc=2475,,,2475,MTOR,9606,Homo sapiens (human),Niacinamide inhibits the reaction [resveratrol results in decreased phosphorylation of MTOR protein]|niacinamide results in increased phosphorylation of MTOR protein,,,PMID:19928762,https://www.ncbi.nlm.nih.gov/pubmed/19928762,19928762,,
165,60484,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609,MYC,10090,Mus musculus (house mouse),"Niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of MYC protein]|niacinamide affects the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of MYC mrna]",,,PMID:24792773,https://www.ncbi.nlm.nih.gov/pubmed/24792773,24792773,,
166,60485,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609,MYC,10090,Mus musculus (house mouse),Niacinamide inhibits the reaction [butylhydroxybutylnitrosamine results in increased expression of and results in increased localization of MYC protein],,,PMID:22028816,https://www.ncbi.nlm.nih.gov/pubmed/22028816,22028816,,
167,60486,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,79035,NABP2,https://ctdbase.org/detail.go?type=gene&acc=79035,,,79035,NABP2,9606,Homo sapiens (human),Trichostatin A promotes the reaction [niacinamide results in increased acetylation of NABP2 protein]|niacinamide promotes the reaction [trichostatin A results in increased acetylation of NABP2 protein]|niacinamide promotes the reaction [trichostatin A results in decreased ubiquitination of NABP2 protein]|trichostatin A promotes the reaction [niacinamide results in decreased ubiquitination of NABP2 protein]|niacinamide results in increased acetylation of NABP2 protein|niacinamide results in decreased ubiquitination of NABP2 protein,,,PMID:26170237,https://www.ncbi.nlm.nih.gov/pubmed/26170237,26170237,,
168,60487,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,10135,NAMPT,https://ctdbase.org/detail.go?type=gene&acc=10135,,,10135,NAMPT,9606,Homo sapiens (human),Niacinamide results in decreased expression of NAMPT protein|[berberine co-treated with niacinamide] results in decreased expression of NAMPT protein,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
169,60488,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,10135,NAMPT,https://ctdbase.org/detail.go?type=gene&acc=10135,,,10135,NAMPT,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [letrozole results in increased expression of NAMPT mrna],,,PMID:32298659,https://www.ncbi.nlm.nih.gov/pubmed/32298659,32298659,,
170,60489,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,9611,NCOR1,https://ctdbase.org/detail.go?type=gene&acc=9611,,,9611,NCOR1,10090,Mus musculus (house mouse),Niacinamide results in decreased expression of NCOR1 protein|niacinamide affects the reaction [PPARG protein binds to NCOR1 protein],,,PMID:22539994,https://www.ncbi.nlm.nih.gov/pubmed/22539994,22539994,,
171,60490,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,51079,NDUFA13,https://ctdbase.org/detail.go?type=gene&acc=51079,,,51079,NDUFA13,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [resveratrol results in increased expression of NDUFA13 mrna]|niacinamide inhibits the reaction [resveratrol results in increased expression of NDUFA13 protein],,,PMID:23891692,https://www.ncbi.nlm.nih.gov/pubmed/23891692,23891692,,
172,60648,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4695,NDUFA2,https://ctdbase.org/detail.go?type=gene&acc=4695,,,4695,NDUFA2,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [resveratrol results in increased expression of NDUFA2 mrna],,,PMID:23891692,https://www.ncbi.nlm.nih.gov/pubmed/23891692,23891692,,
173,60649,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780,NFE2L2,10090,Mus musculus (house mouse),"Metformin promotes the reaction [[streptozocin co-treated with niacinamide] results in increased expression of NFE2L2 protein]|2,5-dihydroxybenzoic acid promotes the reaction [[streptozocin co-treated with niacinamide] results in increased expression of NFE2L2 protein]|[streptozocin co-treated with niacinamide] results in increased expression of NFE2L2 protein",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
174,60650,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780,NFE2L2,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of NFE2L2 mrna]|resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of NFE2L2 protein]|gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of NFE2L2 mrna]|[streptozocin co-treated with niacinamide] results in decreased expression of NFE2L2 mrna|[streptozocin co-treated with niacinamide] results in decreased expression of NFE2L2 protein|gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of NFE2L2 protein],,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
175,60651,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790,NFKB1,10116,Rattus norvegicus (Norway rat),[resveratrol co-treated with niacinamide] inhibits the reaction [[aflatoxin B1 co-treated with ethanol] results in increased expression of NFKB1 mrna],,,PMID:32894639,https://www.ncbi.nlm.nih.gov/pubmed/32894639,32894639,,
176,60652,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843,NOS2,10090,Mus musculus (house mouse),Niacinamide inhibits the reaction [resveratrol results in decreased expression of NOS2 mrna]|niacinamide inhibits the reaction [resveratrol results in decreased expression of NOS2 protein],,,PMID:23735732,https://www.ncbi.nlm.nih.gov/pubmed/23735732,23735732,,
177,60653,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,100169685,NOX2,https://ctdbase.org/detail.go?type=gene&acc=100169685,,,100169685,,10090,Mus musculus (house mouse),"Metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of NOX2 mrna]|[streptozocin co-treated with niacinamide] results in increased expression of NOX2 mrna|2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of NOX2 mrna]",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
178,60654,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,50507,NOX4,https://ctdbase.org/detail.go?type=gene&acc=50507,,,50507,NOX4,10116,Rattus norvegicus (Norway rat),GW 6471 inhibits the reaction [resveratrol inhibits the reaction [niacinamide results in increased expression of NOX4 mrna]]|niacinamide results in increased expression of NOX4 mrna|resveratrol inhibits the reaction [niacinamide results in increased expression of NOX4 mrna],,,PMID:23422569,https://www.ncbi.nlm.nih.gov/pubmed/23422569,23422569,,
179,60655,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728,NQO1,10090,Mus musculus (house mouse),"Metformin promotes the reaction [[streptozocin co-treated with niacinamide] results in increased expression of NQO1 mrna]|[streptozocin co-treated with niacinamide] results in increased expression of NQO1 mrna|2,5-dihydroxybenzoic acid promotes the reaction [[streptozocin co-treated with niacinamide] results in increased expression of NQO1 mrna]",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
180,60799,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,3164,NR4A1,https://ctdbase.org/detail.go?type=gene&acc=3164,,,3164,NR4A1,10090,Mus musculus (house mouse),[glycerol co-treated with succinic acid co-treated with glucose-6-phosphate co-treated with pantothenic acid co-treated with niacinamide] results in increased expression of NR4A1 mRNA,,,PMID:20505214,https://www.ncbi.nlm.nih.gov/pubmed/20505214,20505214,,
181,60800,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4967,OGDH,https://ctdbase.org/detail.go?type=gene&acc=4967,,,4967,OGDH,9606,Homo sapiens (human),Niacinamide inhibits the reaction [1-methyl-4-phenylpyridinium results in decreased activity of OGDH protein],,,PMID:18381761,https://www.ncbi.nlm.nih.gov/pubmed/18381761,18381761,,
182,60801,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Niacinamide results in increased cleavage of PARP1 protein|[berberine co-treated with niacinamide] results in increased cleavage of PARP1 protein,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
183,60802,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Niacinamide results in increased expression of PARP1 protein|niacinamide results in increased expression of PARP1 mRNA,,,PMID:29143419,https://www.ncbi.nlm.nih.gov/pubmed/29143419,29143419,,
184,60803,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,10116,Rattus norvegicus (Norway rat),Niacinamide results in decreased activity of PARP1 protein|niacinamide inhibits the reaction [excitatory amino acid agonists results in decreased expression of PARP1 protein]|niacinamide inhibits the reaction [excitatory amino acid agonists results in increased activity of PARP1 protein],,,PMID:19288225,https://www.ncbi.nlm.nih.gov/pubmed/19288225,19288225,,
185,60804,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Niacinamide results in decreased activity of PARP1 protein,,,PMID:7590113|PMID:8742498,https://www.ncbi.nlm.nih.gov/pubmed/7590113|https://www.ncbi.nlm.nih.gov/pubmed/8742498,7590113|8742498,,
186,60805,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),PARP1 protein affects the chemical synthesis of niacinamide,,,PMID:16026317,https://www.ncbi.nlm.nih.gov/pubmed/16026317,16026317,,
187,60806,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5166,PDK4,https://ctdbase.org/detail.go?type=gene&acc=5166,,,5166,PDK4,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [dexamethasone results in increased expression of PDK4 protein],,,PMID:20181797,https://www.ncbi.nlm.nih.gov/pubmed/20181797,20181797,,
188,60807,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,54704,PDP1,https://ctdbase.org/detail.go?type=gene&acc=54704,,,54704,PDP1,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [dexamethasone results in increased phosphorylation of PDP1 protein],,,PMID:20181797,https://www.ncbi.nlm.nih.gov/pubmed/20181797,20181797,,
189,60808,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5308,PITX2,https://ctdbase.org/detail.go?type=gene&acc=5308,,,5308,PITX2,9606,Homo sapiens (human),Niacinamide results in increased expression of PITX2 mrna|niacinamide results in increased expression of PITX2 protein,,,PMID:29143419,https://www.ncbi.nlm.nih.gov/pubmed/29143419,29143419,,
190,60962,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5376,PMP22,https://ctdbase.org/detail.go?type=gene&acc=5376,,,5376,PMP22,10090,Mus musculus (house mouse),Niacinamide inhibits the reaction [butylhydroxybutylnitrosamine results in decreased expression of and results in decreased localization of PMP22 protein],,,PMID:22028816,https://www.ncbi.nlm.nih.gov/pubmed/22028816,22028816,,
191,60963,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468,PPARG,9615,Canis lupus familiaris (dog),Niacinamide results in increased expression of PPARG protein|resveratrol inhibits the reaction [niacinamide results in increased expression of PPARG protein]|[resveratrol promotes the reaction [SIRT1 protein binds to RUNX2 protein]] inhibits the reaction [niacinamide results in increased expression of pparg]|[resveratrol results in decreased acetylation of RUNX2 protein] inhibits the reaction [niacinamide results in increased expression of pparg]|niacinamide affects the reaction [PPARG protein binds to NCOR1 protein],,,PMID:22539994,https://www.ncbi.nlm.nih.gov/pubmed/22539994,22539994,,
192,60964,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468,PPARG,9823,Sus scrofa (pig),Niacinamide results in increased expression of PPARG mRNA,,,PMID:17851734,https://www.ncbi.nlm.nih.gov/pubmed/17851734,17851734,,
193,60965,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891,PPARGC1A,9031,Gallus gallus (chicken),Niacinamide results in increased stability of PPARGC1A protein|niacinamide inhibits the reaction [tetrachlorodibenzodioxin results in increased acetylation of and results in decreased expression of PPARGC1A protein],,,PMID:20876576,https://www.ncbi.nlm.nih.gov/pubmed/20876576,20876576,,
194,60966,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891,PPARGC1A,9606,Homo sapiens (human),Niacinamide results in increased acetylation of PPARGC1A protein,,,PMID:19071085,https://www.ncbi.nlm.nih.gov/pubmed/19071085,19071085,,
195,60967,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891,PPARGC1A,10090,Mus musculus (house mouse),[niacinamide results in decreased activity of SIRT1 protein] inhibits the reaction [SIRT1 protein results in increased expression of PPARGC1A mrna],,,PMID:23891692,https://www.ncbi.nlm.nih.gov/pubmed/23891692,23891692,,
196,60968,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891,PPARGC1A,10116,Rattus norvegicus (Norway rat),[niacinamide results in decreased activity of SIRT1 protein] which results in increased acetylation of PPARGC1A protein,,,PMID:23422569,https://www.ncbi.nlm.nih.gov/pubmed/23422569,23422569,,
197,60969,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5562,PRKAA1,https://ctdbase.org/detail.go?type=gene&acc=5562,,,5562,PRKAA1,9606,Homo sapiens (human),"Niacinamide inhibits the reaction [6,8-diallyl 5,7-dihydroxy 2-(2-allyl 3-hydroxy 4-methoxyphenyl)1-H benzo(b)pyran-4-one results in increased phosphorylation of PRKAA1 protein]",,,PMID:18482975,https://www.ncbi.nlm.nih.gov/pubmed/18482975,18482975,,
198,60970,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5563,PRKAA2,https://ctdbase.org/detail.go?type=gene&acc=5563,,,5563,PRKAA2,9606,Homo sapiens (human),"Niacinamide inhibits the reaction [6,8-diallyl 5,7-dihydroxy 2-(2-allyl 3-hydroxy 4-methoxyphenyl)1-H benzo(b)pyran-4-one results in increased phosphorylation of PRKAA2 protein]",,,PMID:18482975,https://www.ncbi.nlm.nih.gov/pubmed/18482975,18482975,,
199,61122,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743,PTGS2,9606,Homo sapiens (human),Niacinamide inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]],,,PMID:24145604,https://www.ncbi.nlm.nih.gov/pubmed/24145604,24145604,,
200,61123,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743,PTGS2,9606,Homo sapiens (human),Niacinamide results in increased expression of PTGS2 protein|resveratrol inhibits the reaction [niacinamide results in increased expression of PTGS2 protein],,,PMID:24962570,https://www.ncbi.nlm.nih.gov/pubmed/24962570,24962570,,
201,61124,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5836,PYGL,https://ctdbase.org/detail.go?type=gene&acc=5836,,,5836,PYGL,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] affects the activity of PYGL protein]|[streptozocin co-treated with niacinamide] affects the activity of PYGL protein,,,PMID:19059388,https://www.ncbi.nlm.nih.gov/pubmed/19059388,19059388,,
202,61125,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970,RELA,9606,Homo sapiens (human),Niacinamide results in increased acetylation of and results in increased phosphorylation of RELA protein|resveratrol inhibits the reaction [niacinamide results in increased phosphorylation of and results in increased acetylation of RELA protein],,,PMID:24962570,https://www.ncbi.nlm.nih.gov/pubmed/24962570,24962570,,
203,61126,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970,RELA,10090,Mus musculus (house mouse),"Metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased phosphorylation of RELA protein]|2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased phosphorylation of RELA protein]|[streptozocin co-treated with niacinamide] results in increased phosphorylation of RELA protein",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
204,61127,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970,RELA,10090,Mus musculus (house mouse),Niacinamide inhibits the reaction [resveratrol results in decreased expression of RELA protein modified form],,,PMID:23735732,https://www.ncbi.nlm.nih.gov/pubmed/23735732,23735732,,
205,61128,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970,RELA,10090,Mus musculus (house mouse),Niacinamide promotes the reaction [TNF protein results in increased acetylation of RELA protein],,,PMID:22717288,https://www.ncbi.nlm.nih.gov/pubmed/22717288,22717288,,
206,61129,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970,RELA,10116,Rattus norvegicus (Norway rat),[niacinamide co-treated with streptozocin] results in increased expression of RELA protein|resveratrol inhibits the reaction [[niacinamide co-treated with streptozocin] results in increased expression of RELA protein]|gliclazide inhibits the reaction [[niacinamide co-treated with streptozocin] results in increased expression of RELA protein],,,PMID:20307516,https://www.ncbi.nlm.nih.gov/pubmed/20307516,20307516,,
207,61130,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970,RELA,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of RELA protein]|gliclazide inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of RELA protein]|[streptozocin co-treated with niacinamide] results in increased expression of RELA protein,,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
208,61273,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970,RELA,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [AICA ribonucleotide inhibits the reaction [palmitic acid results in increased phosphorylation of RELA protein]]|niacinamide inhibits the reaction [metformin inhibits the reaction [palmitic acid results in increased phosphorylation of RELA protein]]|niacinamide inhibits the reaction [salicylic acid inhibits the reaction [palmitic acid results in increased phosphorylation of RELA protein]]|niacinamide inhibits the reaction [resveratrol inhibits the reaction [palmitic acid results in increased phosphorylation of RELA protein]],,,PMID:25108154,https://www.ncbi.nlm.nih.gov/pubmed/25108154,25108154,,
209,61274,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970,RELA,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in increased activity of RELA protein|resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased activity of RELA protein],,,PMID:23406761,https://www.ncbi.nlm.nih.gov/pubmed/23406761,23406761,,
210,61275,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6194,RPS6,https://ctdbase.org/detail.go?type=gene&acc=6194,,,6194,RPS6,9606,Homo sapiens (human),[niacinamide results in decreased activity of SIRT1 protein] which results in increased phosphorylation of RPS6 protein,,,PMID:20169165,https://www.ncbi.nlm.nih.gov/pubmed/20169165,20169165,,
211,61276,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6198,RPS6KB1,https://ctdbase.org/detail.go?type=gene&acc=6198,,,6198,RPS6KB1,9606,Homo sapiens (human),Niacinamide results in increased acetylation of RPS6KB1 protein,,,PMID:23248098,https://www.ncbi.nlm.nih.gov/pubmed/23248098,23248098,,
212,61277,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860,RUNX2,9615,Canis lupus familiaris (dog),Niacinamide results in decreased expression of RUNX2 protein|resveratrol inhibits the reaction [niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]]|[resveratrol promotes the reaction [SIRT1 protein binds to RUNX2 protein]] inhibits the reaction [niacinamide results in increased expression of pparg]|niacinamide results in increased acetylation of RUNX2 protein|[resveratrol results in decreased acetylation of RUNX2 protein] inhibits the reaction [niacinamide results in increased expression of pparg]|resveratrol inhibits the reaction [niacinamide results in increased acetylation of RUNX2 protein]|niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]|resveratrol inhibits the reaction [niacinamide results in decreased expression of RUNX2 protein],,,PMID:22539994,https://www.ncbi.nlm.nih.gov/pubmed/22539994,22539994,,
213,61278,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860,RUNX2,10090,Mus musculus (house mouse),Niacinamide results in increased expression of RUNX2 mrna|niacinamide results in decreased expression of RUNX2 mRNA,,,PMID:16813520,https://www.ncbi.nlm.nih.gov/pubmed/16813520,16813520,,
214,61279,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6464,SHC1,https://ctdbase.org/detail.go?type=gene&acc=6464,,,6464,SHC1,9606,Homo sapiens (human),Niacinamide promotes the reaction [[oxygen deficiency co-treated with oxygen] results in increased expression of SHC1 protein],,,PMID:24557422,https://www.ncbi.nlm.nih.gov/pubmed/24557422,24557422,,
215,61280,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6464,SHC1,https://ctdbase.org/detail.go?type=gene&acc=6464,,,6464,SHC1,9606,Homo sapiens (human),Niacinamide results in increased expression of SHC1 protein|niacinamide results in increased expression of SHC1 mRNA,,,PMID:21778425,https://www.ncbi.nlm.nih.gov/pubmed/21778425,21778425,,
216,61281,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9615,Canis lupus familiaris (dog),Resveratrol inhibits the reaction [niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein]]|[resveratrol promotes the reaction [SIRT1 protein binds to RUNX2 protein]] inhibits the reaction [niacinamide results in increased expression of pparg]|resveratrol inhibits the reaction [niacinamide results in decreased expression of SIRT1 protein]|niacinamide results in decreased expression of SIRT1 protein|niacinamide inhibits the reaction [SIRT1 protein binds to RUNX2 protein],,,PMID:22539994,https://www.ncbi.nlm.nih.gov/pubmed/22539994,22539994,,
217,61457,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),[berberine co-treated with niacinamide] results in decreased expression of SIRT1 protein,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
218,61458,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),"Niacinamide inhibits the reaction [1,5-dihydroxyisoquinoline inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased activity of SIRT1 protein]]",,,PMID:25517228,https://www.ncbi.nlm.nih.gov/pubmed/25517228,25517228,,
219,61459,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),Niacinamide inhibits the reaction [icariin inhibits the reaction [[oxygen co-treated with oxygen deficiency] results in decreased expression of SIRT1 protein]],,,PMID:25472572,https://www.ncbi.nlm.nih.gov/pubmed/25472572,25472572,,
220,61460,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),Niacinamide inhibits the reaction [resveratrol results in increased expression of SIRT1 protein]|niacinamide results in decreased expression of SIRT1 protein,,,PMID:19928762,https://www.ncbi.nlm.nih.gov/pubmed/19928762,19928762,,
221,61461,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),Niacinamide inhibits the reaction [salvin inhibits the reaction [[oxygen deficiency co-treated with oxygen] results in decreased expression of SIRT1 protein]]|niacinamide promotes the reaction [[oxygen deficiency co-treated with oxygen] results in decreased expression of SIRT1 protein],,,PMID:24557422,https://www.ncbi.nlm.nih.gov/pubmed/24557422,24557422,,
222,61462,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),Niacinamide results in decreased activity of SIRT1 protein,,,PMID:17103016|PMID:19071085|PMID:19664641|PMID:20169165|PMID:21745208|PMID:21892612|PMID:22385246|PMID:22990594,https://www.ncbi.nlm.nih.gov/pubmed/17103016|https://www.ncbi.nlm.nih.gov/pubmed/19071085|https://www.ncbi.nlm.nih.gov/pubmed/19664641|https://www.ncbi.nlm.nih.gov/pubmed/20169165|https://www.ncbi.nlm.nih.gov/pubmed/21745208|https://www.ncbi.nlm.nih.gov/pubmed/21892612|https://www.ncbi.nlm.nih.gov/pubmed/22385246|https://www.ncbi.nlm.nih.gov/pubmed/22990594,17103016|19071085|19664641|20169165|21745208|21892612|22385246|22990594,,
223,61463,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),[niacinamide results in decreased activity of SIRT1 protein] which results in increased susceptibility to hydrogen peroxide|[niacinamide results in decreased activity of SIRT1 protein] promotes the reaction [hydrogen peroxide results in increased acetylation of TP53 protein],,,PMID:18681908,https://www.ncbi.nlm.nih.gov/pubmed/18681908,18681908,,
224,61464,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),Niacinamide results in decreased activity of [SIRT1 protein results in decreased acetylation of TP53 protein],,,PMID:18482975,https://www.ncbi.nlm.nih.gov/pubmed/18482975,18482975,,
225,61465,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),[niacinamide results in decreased activity of SIRT1 protein] which results in increased expression of CXCL8 mrna|[niacinamide results in decreased activity of SIRT1 protein] which results in decreased expression of DEFB4A mRNA,,,PMID:24894820,https://www.ncbi.nlm.nih.gov/pubmed/24894820,24894820,,
226,61620,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),[niacinamide results in decreased activity of SIRT1 protein] which results in increased phosphorylation of EIF4EBP1 protein|[niacinamide results in decreased activity of SIRT1 protein] which results in increased phosphorylation of RPS6 protein,,,PMID:20169165,https://www.ncbi.nlm.nih.gov/pubmed/20169165,20169165,,
227,61621,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),Niacinamide results in decreased expression of SIRT1 mRNA,,,PMID:21745208,https://www.ncbi.nlm.nih.gov/pubmed/21745208,21745208,,
228,61622,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,40674,Mammalia (mammals),Niacinamide inhibits the reaction [SIRT1 protein results in increased activity of FOXO4 protein],,,PMID:16012755,https://www.ncbi.nlm.nih.gov/pubmed/16012755,16012755,,
229,61623,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10090,Mus musculus (house mouse),Niacinamide inhibits the reaction [[SIRT1 protein binds to UCP2 promoter] which results in decreased expression of UCP2 mrna],,,PMID:16366736,https://www.ncbi.nlm.nih.gov/pubmed/16366736,16366736,,
230,61624,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10090,Mus musculus (house mouse),Niacinamide results in decreased activity of SIRT1 protein,,,PMID:16366736|PMID:34216621,https://www.ncbi.nlm.nih.gov/pubmed/16366736|https://www.ncbi.nlm.nih.gov/pubmed/34216621,16366736|34216621,,
231,61625,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,8600,TNFSF11,https://ctdbase.org/detail.go?type=gene&acc=8600,,,8600,TNFSF11,10090,Mus musculus (house mouse),Niacinamide results in decreased expression of TNFSF11 mRNA,,,PMID:16813520,https://www.ncbi.nlm.nih.gov/pubmed/16813520,16813520,,
232,61626,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10090,Mus musculus (house mouse),Niacinamide inhibits the reaction [resveratrol results in increased expression of SIRT1 mrna]|niacinamide inhibits the reaction [resveratrol results in increased expression of SIRT1 protein]|[niacinamide results in decreased activity of SIRT1 protein] inhibits the reaction [SIRT1 protein results in increased expression of PPARGC1A mrna],,,PMID:23891692,https://www.ncbi.nlm.nih.gov/pubmed/23891692,23891692,,
233,61627,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10090,Mus musculus (house mouse),[niacinamide results in decreased activity of SIRT1 protein] which results in decreased expression of DLG1 mRNA,,,PMID:21232033,https://www.ncbi.nlm.nih.gov/pubmed/21232033,21232033,,
234,61628,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10090,Mus musculus (house mouse),[niacinamide results in decreased activity of SIRT1 protein] which results in decreased susceptibility to resveratrol,,,PMID:23735732,https://www.ncbi.nlm.nih.gov/pubmed/23735732,23735732,,
235,61629,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10116,Rattus norvegicus (Norway rat),[resveratrol co-treated with niacinamide] promotes the reaction [[ethanol co-treated with aflatoxin B1] results in increased expression of SIRT1 protein]|[niacinamide co-treated with resveratrol] promotes the reaction [[ethanol co-treated with aflatoxin B1] results in increased expression of SIRT1 mrna],,,PMID:32894639,https://www.ncbi.nlm.nih.gov/pubmed/32894639,32894639,,
236,61798,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [excitatory amino acid agonists results in decreased expression of and results in decreased activity of SIRT1 protein]|niacinamide inhibits the reaction [SIRT1 protein results in decreased abundance of NAD],,,PMID:19288225,https://www.ncbi.nlm.nih.gov/pubmed/19288225,19288225,,
237,61799,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [FOXO1 protein binds to SIRT1 protein],,,PMID:20181797,https://www.ncbi.nlm.nih.gov/pubmed/20181797,20181797,,
238,61800,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [resveratrol promotes the reaction [pilocarpine results in increased expression of SIRT1 protein]],,,PMID:23211629,https://www.ncbi.nlm.nih.gov/pubmed/23211629,23211629,,
239,61801,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10116,Rattus norvegicus (Norway rat),Niacinamide results in decreased activity of SIRT1 protein,,,PMID:16366736|PMID:19288225|PMID:23479127|PMID:28973641,https://www.ncbi.nlm.nih.gov/pubmed/16366736|https://www.ncbi.nlm.nih.gov/pubmed/19288225|https://www.ncbi.nlm.nih.gov/pubmed/23479127|https://www.ncbi.nlm.nih.gov/pubmed/28973641,16366736|19288225|23479127|28973641,,
240,61802,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10116,Rattus norvegicus (Norway rat),[niacinamide results in decreased activity of SIRT1 protein] which results in decreased susceptibility to fructose|[niacinamide results in decreased activity of SIRT1 protein] inhibits the reaction [fructose results in increased expression of ACACA mrna]|[niacinamide results in decreased activity of SIRT1 protein] inhibits the reaction [fructose results in increased expression of HMGCR mrna]|[niacinamide results in decreased activity of SIRT1 protein] inhibits the reaction [fructose results in increased abundance of cholesterol]|[niacinamide results in decreased activity of SIRT1 protein] inhibits the reaction [fructose results in increased abundance of glucose],,,PMID:21212096,https://www.ncbi.nlm.nih.gov/pubmed/21212096,21212096,,
241,61803,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10116,Rattus norvegicus (Norway rat),[niacinamide results in decreased activity of SIRT1 protein] inhibits the reaction [resveratrol results in decreased expression of AGTR1 mrna]|[niacinamide results in decreased activity of SIRT1 protein] which results in increased expression of AGTR1 mRNA,,,PMID:18420994,https://www.ncbi.nlm.nih.gov/pubmed/18420994,18420994,,
242,61804,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10116,Rattus norvegicus (Norway rat),[niacinamide results in decreased activity of SIRT1 protein] which results in decreased susceptibility to salicylic acid|[niacinamide results in decreased activity of SIRT1 protein] which results in decreased susceptibility to resveratrol|[niacinamide results in decreased activity of SIRT1 protein] which results in decreased susceptibility to metformin|[niacinamide results in decreased activity of SIRT1 protein] which results in decreased susceptibility to AICA ribonucleotide,,,PMID:25108154,https://www.ncbi.nlm.nih.gov/pubmed/25108154,25108154,,
243,61805,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10116,Rattus norvegicus (Norway rat),[niacinamide results in decreased activity of SIRT1 protein] which results in increased acetylation of PPARGC1A protein,,,PMID:23422569,https://www.ncbi.nlm.nih.gov/pubmed/23422569,23422569,,
244,61970,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,10116,Rattus norvegicus (Norway rat),Niacinamide results in decreased expression of SIRT1 protein,,,PMID:22561310,https://www.ncbi.nlm.nih.gov/pubmed/22561310,22561310,,
245,61971,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9823,Sus scrofa (pig),Niacinamide results in decreased expression of SIRT1 mRNA,,,PMID:17851734,https://www.ncbi.nlm.nih.gov/pubmed/17851734,17851734,,
246,61972,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),Niacinamide binds to and results in decreased activity of SIRT1 protein,,,PMID:18849969,https://www.ncbi.nlm.nih.gov/pubmed/18849969,18849969,,
247,61973,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),[niacinamide co-treated with trichostatin A] inhibits the reaction [FOXO1 protein binds to SIRT1 protein],,,PMID:15788402,https://www.ncbi.nlm.nih.gov/pubmed/15788402,15788402,,
248,61974,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411,SIRT1,9606,Homo sapiens (human),Niacinamide results in decreased activity of SIRT1 protein,,,PMID:17452443|PMID:18420994|PMID:18681908|PMID:19303434|PMID:19720090|PMID:20181797|PMID:20429690|PMID:21212096|PMID:21232033|PMID:23022493|PMID:23422569|PMID:23735732|PMID:23770283|PMID:23891692|PMID:24894820|PMID:24962570|PMID:25108154|PMID:26420067,https://www.ncbi.nlm.nih.gov/pubmed/17452443|https://www.ncbi.nlm.nih.gov/pubmed/18420994|https://www.ncbi.nlm.nih.gov/pubmed/18681908|https://www.ncbi.nlm.nih.gov/pubmed/19303434|https://www.ncbi.nlm.nih.gov/pubmed/19720090|https://www.ncbi.nlm.nih.gov/pubmed/20181797|https://www.ncbi.nlm.nih.gov/pubmed/20429690|https://www.ncbi.nlm.nih.gov/pubmed/21212096|https://www.ncbi.nlm.nih.gov/pubmed/21232033|https://www.ncbi.nlm.nih.gov/pubmed/23022493|https://www.ncbi.nlm.nih.gov/pubmed/23422569|https://www.ncbi.nlm.nih.gov/pubmed/23735732|https://www.ncbi.nlm.nih.gov/pubmed/23770283|https://www.ncbi.nlm.nih.gov/pubmed/23891692|https://www.ncbi.nlm.nih.gov/pubmed/24894820|https://www.ncbi.nlm.nih.gov/pubmed/24962570|https://www.ncbi.nlm.nih.gov/pubmed/25108154|https://www.ncbi.nlm.nih.gov/pubmed/26420067,17452443|18420994|18681908|19303434|19720090|20181797|20429690|21212096|21232033|23022493|23422569|23735732|23770283|23891692|24894820|24962570|25108154|26420067,,
249,61975,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,22933,SIRT2,https://ctdbase.org/detail.go?type=gene&acc=22933,,,22933,SIRT2,9606,Homo sapiens (human),[berberine co-treated with niacinamide] results in decreased expression of SIRT2 protein,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
250,61976,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,22933,SIRT2,https://ctdbase.org/detail.go?type=gene&acc=22933,,,22933,SIRT2,9606,Homo sapiens (human),Niacinamide results in decreased activity of SIRT2 protein,,,PMID:17341628,https://www.ncbi.nlm.nih.gov/pubmed/17341628,17341628,,
251,61977,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,23410,SIRT3,https://ctdbase.org/detail.go?type=gene&acc=23410,,,23410,SIRT3,9606,Homo sapiens (human),[berberine co-treated with niacinamide] results in decreased expression of SIRT3 protein,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
252,61978,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,51548,SIRT6,https://ctdbase.org/detail.go?type=gene&acc=51548,,,51548,SIRT6,9031,Gallus gallus (chicken),Niacinamide inhibits the reaction [beta-naphthoflavone results in decreased expression of and results in decreased activity of SIRT6 protein],,,PMID:28536482,https://www.ncbi.nlm.nih.gov/pubmed/28536482,28536482,,
253,62130,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6517,SLC2A4,https://ctdbase.org/detail.go?type=gene&acc=6517,,,6517,SLC2A4,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [letrozole results in decreased expression of SLC2A4 mrna],,,PMID:32298659,https://www.ncbi.nlm.nih.gov/pubmed/32298659,32298659,,
254,62131,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,28250,SLCO1A4,https://ctdbase.org/detail.go?type=gene&acc=28250,,,28250,Slco1a4,10090,Mus musculus (house mouse),SLCO1A4 protein affects the abundance of niacinamide,,,PMID:21561886,https://www.ncbi.nlm.nih.gov/pubmed/21561886,21561886,,
255,62132,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,8773,SNAP23,https://ctdbase.org/detail.go?type=gene&acc=8773,,,8773,SNAP23,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of SNAP23 mrna]|[streptozocin co-treated with niacinamide] results in decreased expression of SNAP23 mRNA,,,PMID:25999625,https://www.ncbi.nlm.nih.gov/pubmed/25999625,25999625,,
256,62133,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647,SOD1,10090,Mus musculus (house mouse),"2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of SOD1 protein]|metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased activity of SOD1 protein]|[streptozocin co-treated with niacinamide] results in decreased activity of SOD1 protein",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
257,62134,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647,SOD1,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in increased expression of SOD1 protein|dronabinol promotes the reaction [[streptozocin co-treated with niacinamide] results in increased expression of SOD1 protein],,,PMID:31081965,https://www.ncbi.nlm.nih.gov/pubmed/31081965,31081965,,
258,62135,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648,SOD2,9606,Homo sapiens (human),Niacinamide promotes the reaction [[oxygen co-treated with oxygen deficiency] results in decreased expression of SOD2 protein],,,PMID:25472572,https://www.ncbi.nlm.nih.gov/pubmed/25472572,25472572,,
259,62136,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648,SOD2,10116,Rattus norvegicus (Norway rat),Niacinamide inhibits the reaction [resveratrol results in increased expression of SOD2 mrna],,,PMID:23891692,https://www.ncbi.nlm.nih.gov/pubmed/23891692,23891692,,
260,62137,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6662,SOX9,https://ctdbase.org/detail.go?type=gene&acc=6662,,,6662,SOX9,9606,Homo sapiens (human),"Niacinamide results in decreased expression of SOX9 protein|resveratrol inhibits the reaction [niacinamide results in decreased expression of SOX9 protein]|4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline inhibits the reaction [niacinamide results in decreased expression of SOX9 protein]",,,PMID:24962570,https://www.ncbi.nlm.nih.gov/pubmed/24962570,24962570,,
261,62138,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878,SQSTM1,10090,Mus musculus (house mouse),Niacinamide inhibits the reaction [sirolimus results in decreased expression of SQSTM1 protein],,,PMID:24238063,https://www.ncbi.nlm.nih.gov/pubmed/24238063,24238063,,
262,62266,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6720,SREBF1,https://ctdbase.org/detail.go?type=gene&acc=6720,,,6720,SREBF1,9606,Homo sapiens (human),Niacinamide inhibits the reaction [platycodin D inhibits the reaction [glucose results in increased expression of SREBF1 protein]],,,PMID:23319015,https://www.ncbi.nlm.nih.gov/pubmed/23319015,23319015,,
263,62267,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6810,STX4,https://ctdbase.org/detail.go?type=gene&acc=6810,,,6810,STX4,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in decreased expression of STX4 mrna|resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of STX4 mrna],,,PMID:25999625,https://www.ncbi.nlm.nih.gov/pubmed/25999625,25999625,,
264,62268,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7015,TERT,https://ctdbase.org/detail.go?type=gene&acc=7015,,,7015,TERT,10029,Cricetulus griseus (Chinese hamster),Niacinamide results in decreased activity of TERT protein,,,PMID:11563329,https://www.ncbi.nlm.nih.gov/pubmed/11563329,11563329,,
265,62269,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040,TGFB1,10090,Mus musculus (house mouse),"Metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of TGFB1 protein]|2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of TGFB1 mrna]|2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of TGFB1 protein]|[streptozocin co-treated with niacinamide] results in increased expression of TGFB1 protein|metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of TGFB1 mrna]|[streptozocin co-treated with niacinamide] results in increased expression of TGFB1 mRNA",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
266,62270,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7042,TGFB2,https://ctdbase.org/detail.go?type=gene&acc=7042,,,7042,TGFB2,9606,Homo sapiens (human),Niacinamide inhibits the reaction [resveratrol inhibits the reaction [TGFB2 protein results in increased expression of COL1A1 mrna]]|niacinamide inhibits the reaction [resveratrol inhibits the reaction [TGFB2 protein results in increased expression of COL1A2 mrna]],,,PMID:25707573,https://www.ncbi.nlm.nih.gov/pubmed/25707573,25707573,,
267,62271,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,25976,TIPARP,https://ctdbase.org/detail.go?type=gene&acc=25976,,,25976,TIPARP,9031,Gallus gallus (chicken),Niacinamide inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of TIPARP mrna],,,PMID:20876576,https://www.ncbi.nlm.nih.gov/pubmed/20876576,20876576,,
268,62272,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124,TNF,9606,Homo sapiens (human),Niacinamide inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of MMP9 protein]]|niacinamide inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]]|niacinamide inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]]|niacinamide inhibits the reaction [[TNF protein co-treated with resveratrol] results in increased expression of MAP1LC3B protein alternative form],,,PMID:24145604,https://www.ncbi.nlm.nih.gov/pubmed/24145604,24145604,,
269,62273,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124,TNF,9606,Homo sapiens (human),Niacinamide results in increased expression of TNF mRNA,,,PMID:22385246,https://www.ncbi.nlm.nih.gov/pubmed/22385246,22385246,,
270,62274,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124,TNF,10090,Mus musculus (house mouse),"Metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of TNF mrna]|2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of TNF protein]|[streptozocin co-treated with niacinamide] results in increased expression of TNF protein|metformin inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of TNF protein]|2,5-dihydroxybenzoic acid inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of TNF mrna]|[streptozocin co-treated with niacinamide] results in increased expression of TNF mRNA",,,PMID:37120126,https://www.ncbi.nlm.nih.gov/pubmed/37120126,37120126,,
271,62424,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124,TNF,10090,Mus musculus (house mouse),Niacinamide promotes the reaction [TNF protein results in increased expression of CD40 mrna]|niacinamide promotes the reaction [TNF protein results in increased acetylation of RELA protein],,,PMID:22717288,https://www.ncbi.nlm.nih.gov/pubmed/22717288,22717288,,
272,62425,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124,TNF,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[niacinamide co-treated with streptozocin] results in increased expression of TNF protein]|gliclazide inhibits the reaction [[niacinamide co-treated with streptozocin] results in increased expression of TNF protein]|[niacinamide co-treated with streptozocin] results in increased expression of TNF protein,,,PMID:20307516,https://www.ncbi.nlm.nih.gov/pubmed/20307516,20307516,,
273,62426,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124,TNF,10116,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in increased expression of TNF protein],,,PMID:21439372,https://www.ncbi.nlm.nih.gov/pubmed/21439372,21439372,,
274,62427,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124,TNF,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in increased expression of TNF protein,,,PMID:21439372|PMID:31081965,https://www.ncbi.nlm.nih.gov/pubmed/21439372|https://www.ncbi.nlm.nih.gov/pubmed/31081965,21439372|31081965,,
275,62428,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,4982,TNFRSF11B,https://ctdbase.org/detail.go?type=gene&acc=4982,,,4982,TNFRSF11B,10090,Mus musculus (house mouse),Niacinamide results in decreased expression of TNFRSF11B mRNA,,,PMID:16813520,https://www.ncbi.nlm.nih.gov/pubmed/16813520,16813520,,
276,62429,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157,TP53,9606,Homo sapiens (human),Niacinamide results in increased phosphorylation of and results in increased acetylation of TP53 protein|[berberine co-treated with niacinamide] results in increased expression of and results in increased acetylation of TP53 protein,,,PMID:26712469,https://www.ncbi.nlm.nih.gov/pubmed/26712469,26712469,,
277,62430,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157,TP53,9606,Homo sapiens (human),Niacinamide inhibits the reaction [tert-butylhydroperoxide results in increased expression of TP53 protein]|niacinamide results in decreased expression of TP53 protein,,,PMID:12782109,https://www.ncbi.nlm.nih.gov/pubmed/12782109,12782109,,
278,62431,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157,TP53,9606,Homo sapiens (human),[niacinamide results in decreased activity of SIRT1 protein] promotes the reaction [hydrogen peroxide results in increased acetylation of TP53 protein],,,PMID:18681908,https://www.ncbi.nlm.nih.gov/pubmed/18681908,18681908,,
279,62432,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157,TP53,9606,Homo sapiens (human),Niacinamide results in decreased activity of [SIRT1 protein results in decreased acetylation of TP53 protein],,,PMID:18482975,https://www.ncbi.nlm.nih.gov/pubmed/18482975,18482975,,
280,62575,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,22059,TRP53,https://ctdbase.org/detail.go?type=gene&acc=22059,,,22059,Trp53,10090,Mus musculus (house mouse),"[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of TRP53 mRNA alternative form]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of TRP53 mRNA alternative form]|[butyric acid co-treated with niacinamide co-treated with glucaric acid] inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein]|niacinamide inhibits the reaction [9,10-dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein]",,,PMID:25478867,https://www.ncbi.nlm.nih.gov/pubmed/25478867,25478867,,
281,62576,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7299,TYR,https://ctdbase.org/detail.go?type=gene&acc=7299,,,7299,TYR,9606,Homo sapiens (human),Niacinamide results in increased expression of TYR protein|niacinamide results in increased expression of TYR mRNA,,,PMID:23738040,https://www.ncbi.nlm.nih.gov/pubmed/23738040,23738040,,
282,62577,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,7351,UCP2,https://ctdbase.org/detail.go?type=gene&acc=7351,,,7351,UCP2,10090,Mus musculus (house mouse),Niacinamide inhibits the reaction [[SIRT1 protein binds to UCP2 promoter] which results in decreased expression of UCP2 mrna],,,PMID:16366736,https://www.ncbi.nlm.nih.gov/pubmed/16366736,16366736|16366736,,
283,62578,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,6844,VAMP2,https://ctdbase.org/detail.go?type=gene&acc=6844,,,6844,VAMP2,10116,Rattus norvegicus (Norway rat),[streptozocin co-treated with niacinamide] results in decreased expression of VAMP2 mrna|resveratrol inhibits the reaction [[streptozocin co-treated with niacinamide] results in decreased expression of VAMP2 mrna],,,PMID:25999625,https://www.ncbi.nlm.nih.gov/pubmed/25999625,25999625,,
284,62579,936,Comparative Toxicogenomics Database (CTD),Niacinamide,D009536,Niacinamide,https://ctdbase.org/detail.go?type=chem&acc=D009536,389692,MAFA,https://ctdbase.org/detail.go?type=gene&acc=389692,,,389692,MAFA,9606,Homo sapiens (human),Niacinamide inhibits the reaction [glucose inhibits the reaction [MAFA protein binds to INS promoter]],,,PMID:16505238,https://www.ncbi.nlm.nih.gov/pubmed/16505238,16505238,,
285,76468,936,Drug Gene Interaction database (DGIdb),Niacinamide,,NIACINAMIDE,https://www.dgidb.org/drugs/NIACINAMIDE,,SIRT1,https://www.dgidb.org/genes/SIRT1,,,23411,SIRT1,9606,Homo sapiens (human),,,,PMID:25884115,https://www.ncbi.nlm.nih.gov/pubmed/25884115,25884115,,
286,76469,936,DrugBank,Niacinamide,DB02701,Nicotinamide,https://www.drugbank.ca/drugs/DB02701,BE0001241,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,https://www.drugbank.ca/bio_entities/BE0001241,Q10588,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,683,BST1,9606,Homo sapiens (human),Product of,,,PMID:16690024|PMID:9378973,https://www.ncbi.nlm.nih.gov/pubmed/16690024|https://www.ncbi.nlm.nih.gov/pubmed/9378973,16690024|9378973,,"Moreschi I, Bruzzone S, Melone L, De Flora A, Zocchi E: NAADP+ synthesis from cADPRP and nicotinic acid by ADP-ribosyl cyclases. Biochem Biophys Res Commun. 2006 Jun 30;345(2):573-80. Epub 2006 Apr 27.|Ferrero E, Malavasi F: Human CD38, a leukocyte receptor and ectoenzyme, is a member of a novel eukaryotic gene family of nicotinamide adenine dinucleotide+-converting enzymes: extensive structural homology with the genes for murine bone marrow stromal cell antigen 1 and aplysian ADP-ribosyl cyclase. J Immunol. 1997 Oct 15;159(8):3858-65."
287,76470,936,DrugBank,Niacinamide,DB02701,Nicotinamide,https://www.drugbank.ca/drugs/DB02701,BE0001869,Exotoxin A,https://www.drugbank.ca/bio_entities/BE0001869,P11439,Exotoxin A,877850,toxA,208964,Pseudomonas aeruginosa PAO1,Product of,,,PMID:8692916|PMID:6419320|PMID:14705944,https://www.ncbi.nlm.nih.gov/pubmed/8692916|https://www.ncbi.nlm.nih.gov/pubmed/6419320|https://www.ncbi.nlm.nih.gov/pubmed/14705944,8692916|6419320|14705944,,"Li M, Dyda F, Benhar I, Pastan I, Davies DR: Crystal structure of the catalytic domain of Pseudomonas exotoxin A complexed with a nicotinamide adenine dinucleotide analog: implications for the activation process and for ADP ribosylation. Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):6902-6.|Pollack M: The role of exotoxin A in pseudomonas disease and immunity. Rev Infect Dis. 1983 Nov-Dec;5 Suppl 5:S979-84. doi: 10.1093/clinids/5.supplement_5.s979.|Armstrong S, Merrill AR: Toward the elucidation of the catalytic mechanism of the mono-ADP-ribosyltransferase activity of Pseudomonas aeruginosa exotoxin A. Biochemistry. 2004 Jan 13;43(1):183-94. doi: 10.1021/bi034772u."
288,76471,936,DrugBank,Niacinamide,DB02701,Nicotinamide,https://www.drugbank.ca/drugs/DB02701,BE0003362,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",https://www.drugbank.ca/bio_entities/BE0003362,Q9NXA8,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",23408,SIRT5,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,"Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.|Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.|Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
289,76616,936,DrugBank,Niacinamide,DB02701,Nicotinamide,https://www.drugbank.ca/drugs/DB02701,BE0000425,L-lactate dehydrogenase A chain,https://www.drugbank.ca/bio_entities/BE0000425,P00338,L-lactate dehydrogenase A chain,3939,LDHA,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,"Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.|Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.|Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
290,76617,936,DrugBank,Niacinamide,DB02701,Nicotinamide,https://www.drugbank.ca/drugs/DB02701,BE0001717,Poly [ADP-ribose] polymerase 1,https://www.drugbank.ca/bio_entities/BE0001717,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Binder,,,PMID:11752352,https://www.ncbi.nlm.nih.gov/pubmed/11752352,11752352,,"Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5."
291,76618,936,DrugBank,Niacinamide,DB02701,Nicotinamide,https://www.drugbank.ca/drugs/DB02701,BE0002363,Cytochrome P450 2D6,https://www.drugbank.ca/bio_entities/BE0002363,P10635,Cytochrome P450 2D6,1565,CYP2D6,9606,Homo sapiens (human),Inhibitor,,,PMID:15081432,https://www.ncbi.nlm.nih.gov/pubmed/15081432,15081432,,"Gaudineau C, Auclair K: Inhibition of human P450 enzymes by nicotinic acid and nicotinamide. Biochem Biophys Res Commun. 2004 May 7;317(3):950-6. doi: 10.1016/j.bbrc.2004.03.137."
292,76619,936,DrugBank,Niacinamide,DB02701,Nicotinamide,https://www.drugbank.ca/drugs/DB02701,BE0003533,Cytochrome P450 2E1,https://www.drugbank.ca/bio_entities/BE0003533,P05181,Cytochrome P450 2E1,1571,CYP2E1,9606,Homo sapiens (human),Substrate|Inhibitor,,,PMID:15081432|PMID:23418369,https://www.ncbi.nlm.nih.gov/pubmed/15081432|https://www.ncbi.nlm.nih.gov/pubmed/23418369,15081432|23418369,,"Gaudineau C, Auclair K: Inhibition of human P450 enzymes by nicotinic acid and nicotinamide. Biochem Biophys Res Commun. 2004 May 7;317(3):950-6. doi: 10.1016/j.bbrc.2004.03.137.|Real AM, Hong S, Pissios P: Nicotinamide N-oxidation by CYP2E1 in human liver microsomes. Drug Metab Dispos. 2013 Mar;41(3):550-3. doi: 10.1124/dmd.112.049734. Epub 2012 Dec 21."
293,76620,936,DrugBank,Niacinamide,DB02701,Nicotinamide,https://www.drugbank.ca/drugs/DB02701,BE0002638,Cytochrome P450 3A4,https://www.drugbank.ca/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576,CYP3A4,9606,Homo sapiens (human),Inhibitor,,,PMID:15081432|PMID:15762770,https://www.ncbi.nlm.nih.gov/pubmed/15081432|https://www.ncbi.nlm.nih.gov/pubmed/15762770,15081432|15762770,,"Gaudineau C, Auclair K: Inhibition of human P450 enzymes by nicotinic acid and nicotinamide. Biochem Biophys Res Commun. 2004 May 7;317(3):950-6. doi: 10.1016/j.bbrc.2004.03.137.|Zhou S, Yung Chan S, Cher Goh B, Chan E, Duan W, Huang M, McLeod HL: Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs. Clin Pharmacokinet. 2005;44(3):279-304. doi: 10.2165/00003088-200544030-00005."
294,112172,936,Therapeutic Target Database (TTD),Niacinamide,D06NVJ,Nicotinamide,https://idrblab.net/ttd/data/drug/details/D06NVJ,T06273,Poly [ADP-ribose] polymerase 1 (PARP1),https://idrblab.net/ttd/data/target/details/T06273,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),Binder,,,,,,,
295,125376,936,BindingDB,Niacinamide,27507,3-Pyridinecarboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27507,9822,Sirtuin-6 (SIRT6),https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9822,Q8N6T7,NAD-dependent protein deacetylase sirtuin-6,51548,SIRT6,9606,Homo sapiens (human),,IC50 (nM),189400.0,PMID:28222243,https://www.ncbi.nlm.nih.gov/pubmed/28222243,28222243,,
296,295807,936,BindingDB,Niacinamide,27507,3-Pyridinecarboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27507,232,Poly [ADP-ribose] polymerase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=232,P09874,Poly [ADP-ribose] polymerase 1,142,PARP1,9606,Homo sapiens (human),,IC50 (nM),50119.0,PMID:18809672,https://www.ncbi.nlm.nih.gov/pubmed/18809672,18809672,,
297,295808,936,BindingDB,Niacinamide,27507,3-Pyridinecarboxamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=27507,233,poly-ADP-ribose polymerase 2 (PARP2),https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=233,O88554,Poly [ADP-ribose] polymerase 2,11546,Parp2,10090,Mus musculus (house mouse),,IC50 (nM),208930.0,PMID:18809672,https://www.ncbi.nlm.nih.gov/pubmed/18809672,18809672,,
